RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: lung non-small cell carcinoma
Accession: DOID:3908
browse the term
Definition: A lung carcinoma that is characterized as any type of epithelial lung cancer other than small cell lung carcinoma. (DO)
Synonyms: exact_synonym: NSCLC; non-small cell lung cancer; non-small-cell lung carcinomas; nonsmall cell lung cancer
related_synonym: NONSMALL CELL LUNG CANCER SUPPRESSOR; nonsmall cell lung cancer, resistance to tyrosine kinase inhibitor in; nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic
primary_id: MESH:D002289 ; MIM:603040 ; RDO:0008878
alt_id: DOID:9000424
xref: EFO:0003060 ; NCI:C2926
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
treatment
ISO
DNA:SNPs: :2677G>T, 3435C>T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17534875 PMID:20627363
RGD:11080964
NCBI chr 9:93,049,955...93,146,469
G
ABCC2
ATP binding cassette subfamily C member 2
treatment
ISO
DNA:SNPs: :-24C>T, 3972C>T(human)
RGD
PMID:17534875
RGD:11080964
NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,582...111,038,898
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
treatment
ISO
human cells in mouse model
RGD
PMID:26758680
RGD:126925226
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
ACVR1B
activin A receptor type 1B
susceptibility
ISO
DNA:SNP:intron:rs12809597(human)
RGD
PMID:22586632
RGD:151665491
NCBI chr 5:17,314,322...17,350,726
Ensembl chr 5:17,314,276...17,350,722
G
ADA
adenosine deaminase
ISO
protein:decreased expression:lymphocyte,erythrocyte:
RGD
PMID:31375946
RGD:152995295
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
G
ADAM28
ADAM metallopeptidase domain 28
treatment
ISO
DNA:hypermethylation:promoter
RGD
PMID:21429053 PMID:22354764
RGD:153297789 RGD:153298914
NCBI chr14:8,375,169...8,438,622
Ensembl chr14:8,375,212...8,438,615
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027488
NCBI chr13:190,277,175...190,285,957
Ensembl chr13:190,276,430...190,286,214
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:decreased expression:lung (human)
RGD
PMID:15539404
RGD:7245515
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
AKT1
AKT serine/threonine kinase 1
treatment ameliorates
ISO
human cells in mouse model human cells in mouse model
RGD
PMID:23632475 PMID:32276600
RGD:150404268 RGD:151357000
G
AKT3
AKT serine/threonine kinase 3
disease_progression
ISO
RGD
PMID:19846969
RGD:13432583
NCBI chr10:16,441,465...16,741,745
Ensembl chr10:16,441,447...16,741,337
G
ALB
albumin
disease_progression
ISO
RGD
PMID:23778417
RGD:11036091
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ALK
ALK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17625570 PMID:20979469 PMID:20979473 PMID:21102269 PMID:21336183 PMID:21587085 PMID:21757253 PMID:21767331 PMID:21791641 PMID:21823889 PMID:21904575 PMID:21933749 PMID:22215748 PMID:22277784 PMID:22282074 PMID:22286583 PMID:22508824 PMID:22568572 PMID:22617245 PMID:22713522 PMID:22787409 PMID:22887466 PMID:22920921 PMID:22954507 PMID:22968692 PMID:22986231 PMID:23020724 PMID:23686600 More...
NCBI chr 3:109,411,146...110,105,755
G
AMD1
adenosylmethionine decarboxylase 1
disease_progression
ISO
DNA:SNP: :rs1279590(human)
RGD
PMID:30650190
RGD:14390072
NCBI chr 1:76,839,448...76,863,745
Ensembl chr 1:76,839,731...76,863,738
G
APAF1
apoptotic peptidase activating factor 1
ISO
mRNA:decreased expression:lung
RGD
PMID:28982084
RGD:13703106
NCBI chr 5:85,166,616...85,258,751
Ensembl chr 5:85,166,628...85,258,364
G
APC
APC regulator of WNT signaling pathway
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18337602
NCBI chr 2:116,913,354...116,985,303
Ensembl chr 2:116,812,582...117,034,887
G
AREG
amphiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427 PMID:16230376
NCBI chr 8:70,417,935...70,428,106
Ensembl chr 8:70,417,923...70,428,102
G
ARID1A
AT-rich interaction domain 1A
disease_progression treatment
ISO
protein:decreased expression:lung (human) DNA:mutations
RGD
PMID:24566899 PMID:32791957
RGD:126848781 RGD:126848874
NCBI chr 6:84,049,729...84,124,302
Ensembl chr 6:84,049,087...84,123,349
G
ARID1B
AT-rich interaction domain 1B
treatment
ISO
DNA:mutations
RGD
PMID:32791957
RGD:126848874
NCBI chr 1:9,791,627...10,227,381
Ensembl chr 1:9,791,633...10,227,502
G
ARPC5
actin related protein 2/3 complex subunit 5
ISO
mRNA:increased expression:lung (human)
RGD
PMID:22089643
RGD:11049488
NCBI chr 9:124,839,062...124,847,906
Ensembl chr 9:124,837,765...124,848,105
G
ATF3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr 9:130,772,259...130,829,678
Ensembl chr 9:130,772,262...130,785,506
G
ATM
ATM serine/threonine kinase
susceptibility treatment
ISO
DNA:SNPs,haplotypes:intron: (rs227060, rs170548) (human) human cells in mouse model
RGD
PMID:17582598 PMID:23632475
RGD:150383340 RGD:150404268
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,657...36,759,552
G
AVEN
apoptosis and caspase activation inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr 7:80,447,337...80,640,120
Ensembl chr 7:80,447,524...80,640,119
G
AXIN1
axin 1
disease_progression
ISO
protein:decreased expression:lung (human)
RGD
PMID:19735876
RGD:150530290
NCBI chr 3:41,344,908...41,393,999
Ensembl chr 3:41,337,071...41,393,997
G
AXL
AXL receptor tyrosine kinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22751098
NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914
G
BAD
BCL2 associated agonist of cell death
disease_progression
ISO
protein:decreased expression:lung
RGD
PMID:21918885 PMID:24092988
RGD:13432584 RGD:13434906
NCBI chr 2:7,831,192...7,842,864
Ensembl chr 2:7,830,920...7,842,863
G
BAG6
BAG cochaperone 6
susceptibility
ISO
DNA:SNP: :rs3117582(human)
RGD
PMID:25884493
RGD:14390136
NCBI chr 7:23,756,897...23,768,659
Ensembl chr 7:23,756,897...23,768,666
G
BAMBI
BMP and activin membrane bound inhibitor
ISO
mRNA,protein:increased expression:lung:
RGD
PMID:20716422
RGD:14390157
NCBI chr10:40,053,368...40,058,590
Ensembl chr10:40,053,355...40,060,319
G
BARD1
BRCA1 associated RING domain 1
disease_progression
ISO
RGD
PMID:21815143
RGD:127229947
NCBI chr15:117,049,483...117,135,889
Ensembl chr15:117,047,845...117,175,851
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
human cells in mouse model
RGD
PMID:23632475
RGD:150404268
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
G
BBC3
BCL2 binding component 3
treatment
ISO
human cells in mouse model
RGD
PMID:23632475
RGD:150404268
NCBI chr 6:53,037,103...53,046,902
Ensembl chr 6:53,037,104...53,045,685
G
BCL11A
BCL11 transcription factor A
severity
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:23758992
RGD:11099968
NCBI chr 3:81,195,217...81,296,165
Ensembl chr 3:81,196,294...81,296,382
G
BCORL1
BCL6 corepressor like 1
severity
ISO
RGD
PMID:26648304
RGD:11342082
NCBI chr X:106,547,754...106,613,130
Ensembl chr X:106,549,139...106,612,894
G
BEND4
BEN domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28722770
NCBI chr 8:33,137,738...33,177,702
Ensembl chr 8:33,143,262...33,177,814
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates ameliorates
ISO
protein:increased expression:lung (human) DNA:SNP:intron: (rs11225211) (human)
RGD
PMID:20959404 PMID:27737687 PMID:32905523
RGD:152998985 RGD:152999005 RGD:153297804
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,002,734...33,020,242
G
BIRC5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16382892
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:2102266 PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:14612909 PMID:14681681 PMID:14688025 PMID:15001635 PMID:15016963 PMID:15035987 PMID:15046639 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15488754 PMID:15687339 PMID:15753399 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16772349 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17314276 PMID:17374713 PMID:17488796 PMID:17785355 PMID:18039235 PMID:18368129 PMID:18398503 PMID:18413255 PMID:19206169 PMID:19363522 PMID:19376813 PMID:19383316 PMID:19571295 PMID:19593635 PMID:19794125 PMID:19913317 PMID:20186801 PMID:20818844 PMID:20823850 PMID:21107320 PMID:21107323 PMID:21190184 PMID:21204800 PMID:21343559 PMID:21716161 PMID:22039425 PMID:22113612 PMID:22281684 PMID:22535154 PMID:22892241 PMID:23093928 PMID:23302800 PMID:23352452 PMID:23680146 PMID:23685455 PMID:23756559 PMID:23907581 PMID:24033266 PMID:24512911 PMID:24670642 PMID:24717435 PMID:25079330 PMID:25155755 PMID:25741868 PMID:25950823 PMID:28492532 PMID:28854169 PMID:29595366 PMID:29925953 PMID:31891627 PMID:32978145 PMID:33522658 PMID:34476331 More...
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
BRCA1
BRCA1 DNA repair associated
disease_progression treatment
ISO
DNA:hypermethylation:promoter
RGD
PMID:21575522 PMID:23128816 PMID:23335114 PMID:24443257
RGD:126925968 RGD:127229935 RGD:127229948 RGD:127229949
NCBI chr12:19,788,087...19,854,515
Ensembl chr12:19,786,020...19,854,668
G
BRD7
bromodomain containing 7
disease_progression
ISO
protein:increased expression:lung:
RGD
PMID:22008115
RGD:9586442
NCBI chr 6:34,478,008...34,519,622
Ensembl chr 6:34,478,012...34,519,663
G
BTK
Bruton tyrosine kinase
ameliorates
ISO
mRNA:increased expression:lung (human)
RGD
PMID:32623229
RGD:151347854
NCBI chr X:82,981,512...83,014,475
Ensembl chr X:82,981,515...83,014,573
G
CA12
carbonic anhydrase 12
disease_progression
ISO
RGD
PMID:20521252 PMID:23910904
RGD:155226863 RGD:155226864
NCBI chr 1:108,649,277...108,710,658
Ensembl chr 1:108,649,271...108,710,651
G
CA9
carbonic anhydrase 9
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23910904 PMID:30381462
RGD:155226863
NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822
G
CALR
calreticulin
ameliorates
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:26842877 PMID:29228584
RGD:150521685 RGD:150521696
NCBI chr 2:66,098,263...66,102,074
Ensembl chr 2:66,098,229...66,102,132
G
CASP3
caspase 3
ISO
DNA:SNP: :77G>A (human) mRNA:increased expression:lung
RGD
PMID:16231180 PMID:20661084
RGD:13434908 RGD:13434909
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP6
caspase 6
ISO
mRNA:increased expression:lung
RGD
PMID:16231180
RGD:13434909
NCBI chr 8:112,519,450...112,534,315
Ensembl chr 8:112,520,629...112,537,045
G
CASP7
caspase 7
ISO
DNA:SNP: :rs2227310 (human)
RGD
PMID:20661084
RGD:13434908
NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
G
CASP8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20471133
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
no_association
ISO
DNA:SNP:exon:rs1052571 (human) DNA, mRNA:SNP, decreased expression:exon, lung:rs1052576 (human) mRNA:splice variant:lung mRNA:increased expression:lung DNA:SNP: :rs4645981 (human)
RGD
PMID:16231180 PMID:17285546 PMID:20661084 PMID:20972334
RGD:13434907 RGD:13434908 RGD:13434909 RGD:9999427
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11731445
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CBL
Cbl proto-oncogene
ISO
DNA:missense mutations, loss of heterozygosity:multiple (human)
RGD
PMID:20126411
RGD:11576301
NCBI chr 9:46,416,937...46,512,855
Ensembl chr 9:46,416,938...46,512,834
G
CBLB
Cbl proto-oncogene B
no_association treatment disease_progression
ISO
DNA:SNPs: :rs3772534 (human) DNA:SNP,haplotype: :rs2305035(human) DNA:SNPs: :rs2305035, rs9657904 (human)
RGD
PMID:26732495 PMID:29707316
RGD:126925239 RGD:150540334
NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056
G
CCNB1
cyclin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34837450
NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
G
CCND1
cyclin D1
disease_progression treatment
ISO
mRNA:splice variant DNA:amplification DNA:SNP: :870A>G (human)
RGD
PMID:9462706 PMID:16406195 PMID:18715616 PMID:26055143
RGD:11052612 RGD:13434924 RGD:13434926 RGD:13434928
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCND2
cyclin D2
ISO
mRNA:increased expression:lung protein:increased expression:lung
RGD
PMID:30227870 PMID:31253987
RGD:151665100 RGD:151665108
NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571
G
CCNE1
cyclin E1
disease_progression
ISO
RGD
PMID:11212263
RGD:13673913
NCBI chr 6:39,919,541...39,933,224
Ensembl chr 6:39,919,624...39,933,363
G
CCNH
cyclin H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 2:94,980,938...95,019,053
Ensembl chr 2:94,980,941...95,018,634
G
CD74
CD74 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22919003
NCBI chr 2:151,402,210...151,409,924
Ensembl chr 2:151,402,211...151,409,833
G
CD9
CD9 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr 5:64,420,177...64,459,783
Ensembl chr 5:64,420,182...64,460,304
G
CDA
cytidine deaminase
ISO
DNA:snp:cds:p.K27Q (human)
RGD
PMID:18347182
RGD:2316365
NCBI chr 6:78,824,248...78,849,154
Ensembl chr 6:78,824,270...78,849,547
G
CDH13
cadherin 13
ISO
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter
CTD RGD
PMID:11389090 PMID:18337602
RGD:2293545
NCBI chr 6:4,809,752...5,832,188
Ensembl chr 6:4,808,255...5,832,415
G
CDK4
cyclin dependent kinase 4
treatment disease_progression
ISO
RGD
PMID:24496383 PMID:24959380
RGD:13464275 RGD:13464276
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CDK6
cyclin dependent kinase 6
treatment
ISO
RGD
PMID:23591808 PMID:27874949
RGD:13464321 RGD:13464324
NCBI chr 9:72,510,858...72,765,631
Ensembl chr 9:72,518,101...72,764,129
G
CDKN1A
cyclin dependent kinase inhibitor 1A
treatment
ISO
human cells in mouse model
RGD
PMID:23632475
RGD:150404268
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,354,672...32,363,761
G
CDKN1B
cyclin dependent kinase inhibitor 1B
disease_progression
ISO
RGD
PMID:9500468
RGD:13673920
NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18337602 PMID:19375815
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CDKN2B
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hypermethylation:promoter
RGD
PMID:11445839
RGD:13673922
NCBI chr 1:200,666,250...200,770,880
Ensembl chr 1:200,761,004...200,766,056
G
CENPA
centromere protein A
severity
ISO
mRNA:increased expression:lung (human)
RGD
PMID:30008938
RGD:36947379
NCBI chr 3:112,263,912...112,272,638
Ensembl chr 3:112,263,915...112,272,621
G
CERT1
ceramide transporter 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr 2:84,410,425...84,538,018
Ensembl chr 2:84,413,340...84,537,783
G
CHFR
checkpoint with forkhead and ring finger domains
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705357
NCBI chr14:22,654,462...22,683,970
Ensembl chr14:22,654,481...22,683,966
G
CHGA
chromogranin A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21595568
NCBI chr 7:114,345,542...114,357,799
Ensembl chr 7:114,345,305...114,358,075
G
CHI3L1
chitinase 3 like 1
severity
ISO
protein:increased secretion:serum (human)
RGD
PMID:20564116
RGD:4892660
NCBI chr 9:113,885,541...113,895,033
Ensembl chr 9:113,885,542...113,895,131
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
disease_progression susceptibility
ISO
DNA:SNP: :rs6495309(human) DNA:SNP:exon: (rs1051730) (human)
RGD
PMID:21747048 PMID:22722785
RGD:151347532 RGD:151660346
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,899...47,384,303
G
CHRNA5
cholinergic receptor nicotinic alpha 5 subunit
disease_progression
ISO
DNA:SNP: :rs667282(human)
RGD
PMID:27050379
RGD:150527847
NCBI chr 7:47,382,860...47,425,871
Ensembl chr 7:47,383,792...47,425,841
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ameliorates
ISO
RGD
PMID:19151195 PMID:19326440
RGD:151667906 RGD:151667908
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CHRNB4
cholinergic receptor nicotinic beta 4 subunit
severity
ISO
RGD
PMID:25172267
RGD:151361147
NCBI chr 7:47,338,819...47,359,064
G
CLPTM1L
CLPTM1 like
no_association disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs31490(human) DNA:SNPs: :rs4975616,rs401681(human) DNA:SNPs:: rs401681,rs4975616(human)
CTD RGD
PMID:22675468 PMID:24175795 PMID:24679952 PMID:27982019
RGD:150530500 RGD:150530632 RGD:150530644
NCBI chr16:79,237,000...79,248,503
Ensembl chr16:79,237,061...79,248,500
G
CMPK1
cytidine/uridine monophosphate kinase 1
severity
ISO
DNA:snps:intron:IVS1+1057C>A rs4492666, IVS1-928C>A rs11211524 (human)
RGD
PMID:21642870
RGD:5133252
NCBI chr 6:164,161,439...164,197,429
Ensembl chr 6:164,162,518...164,197,379
G
COL7A1
collagen type VII alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30381462
NCBI chr13:31,262,750...31,295,112
G
CORO1C
coronin 1C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr14:42,062,468...42,145,130
Ensembl chr14:42,062,893...42,145,123
G
CRADD
CASP2 and RIPK1 domain containing adaptor with death domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35305058
NCBI chr 5:89,257,603...89,480,414
Ensembl chr 5:89,267,944...89,479,712
G
CSF1R
colony stimulating factor 1 receptor
severity ameliorates
ISO
DNA:missense mutation:CDS:p.H362R (rs10079250) (human) mRNA,protein:increased expression:lung (human) human cells in a mouse model mRNA:decreased expression:lung (human)
RGD
PMID:24451080 PMID:27486763 PMID:28449811 PMID:33428598
RGD:150524288 RGD:150524292 RGD:150524294 RGD:150524295
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSF3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7692001
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
G
CST6
cystatin E/M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr 2:6,323,737...6,325,519
Ensembl chr 2:6,323,740...6,325,415
G
CTDSPL
CTD small phosphatase like
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:22491060
RGD:153350086
NCBI chr13:22,707,736...22,828,773
Ensembl chr13:22,707,444...22,825,400
G
CUX1
cut like homeobox 1
exacerbates
ISO
mRNA:increased expression:lung (human)
RGD
PMID:28405678
RGD:152985544
NCBI chr 3:9,317,145...9,669,999
Ensembl chr 3:9,317,140...9,669,998
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15956251
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCR4
C-X-C motif chemokine receptor 4
disease_progression
ISO
protein:increased expression:lung (human)
RGD
PMID:22977534
RGD:152023747
NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232
G
CYCS
cytochrome c, somatic
severity treatment
ISO
protein:decreased expression:serum
RGD
PMID:25578497
RGD:13792769
NCBI chr18:47,169,921...47,172,212
Ensembl chr18:47,169,866...47,173,866
G
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr 6:34,058,091...34,121,939
Ensembl chr 6:34,059,081...34,121,264
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
exacerbates susceptibility disease_progression
ISO
mRNA:increased expression:lung (human) DNA:SNPs:multiple (human) DNA:SNPs:CDS, 3' utr: (rs6068816, rs4809957) (human) DNA:SNP:exon, intron: (rs6068816, rs2181874) (human) DNA:SNP:intron 4: (rs3787554) (human)
RGD
PMID:17671213 PMID:21169243 PMID:23435876 PMID:25544771 PMID:27669215 PMID:29250167 PMID:29726119 More...
RGD:151361179 RGD:151361182 RGD:151361185 RGD:151665175 RGD:151665789 RGD:151708738 RGD:151708739
NCBI chr17:55,110,546...55,130,328
Ensembl chr17:55,110,590...55,130,363
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16142352
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
G
DAB2IP
DAB2 interacting protein
disease_progression
ISO
protein:decreased expression:lung (human)
RGD
PMID:31849482
RGD:151665206
NCBI chr 1:261,732,280...261,859,833
Ensembl chr 1:261,659,785...261,859,830
G
DAPK1
death associated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11313923
NCBI chr10:27,724,644...27,954,708
Ensembl chr10:27,724,648...27,954,350
G
DDR1
discoidin domain receptor tyrosine kinase 1
disease_progression
ISO
RGD
PMID:17299390
RGD:150429714
NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,777...23,391,585
G
DDR2
discoidin domain receptor tyrosine kinase 2
ISO
mRNA:decreased expression:lung ClinVar Annotator: match by term: Non-small cell lung carcinoma
RGD ClinVar
PMID:17299390 PMID:22328973 PMID:28492532
RGD:150429714
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296
G
DEUP1
deuterosome assembly protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 9:25,688,394...25,893,105
Ensembl chr 9:25,689,034...25,893,096
G
DIABLO
diablo IAP-binding mitochondrial protein
ISO
mRNA:increased expression:lung
RGD
PMID:16231180
RGD:13434909
NCBI chr14:30,498,885...30,519,846
Ensembl chr14:30,498,900...30,520,070
G
DNAI7
dynein axonemal intermediate chain 7
ameliorates
ISO
RGD
PMID:24860162
RGD:152998908
NCBI chr 5:48,555,637...48,651,370
Ensembl chr 5:48,555,688...48,651,365
G
DNMT1
DNA methyltransferase 1
treatment
ISO
RGD
PMID:32211850
RGD:126848780
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
G
DUSP3
dual specificity phosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr12:19,336,308...19,349,739
Ensembl chr12:19,336,354...19,349,734
G
E2F1
E2F transcription factor 1
severity disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12237873 PMID:12358350 PMID:23543735 PMID:28498400 PMID:29754146
RGD:13464333 RGD:13464342 RGD:13464343 RGD:9590260
NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883
G
E2F2
E2F transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29754146
NCBI chr 6:81,377,922...81,398,862
Ensembl chr 6:81,377,924...81,398,867
G
E2F3
E2F transcription factor 3
disease_progression
ISO
DNA:SNP: :rs3806116 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:27557513 PMID:29754146
RGD:13464345
NCBI chr 7:15,793,519...15,870,213
Ensembl chr 7:15,794,178...15,870,204
G
E2F5
E2F transcription factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29754146
NCBI chr 4:51,478,399...51,512,617
Ensembl chr 4:51,478,050...51,512,718
G
E2F6
E2F transcription factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29754146
NCBI chr 3:125,248,232...125,271,039
Ensembl chr 3:125,249,269...125,271,037
G
E2F7
E2F transcription factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29754146
NCBI chr 5:104,126,924...104,163,582
Ensembl chr 5:104,127,731...104,163,212
G
E2F8
E2F transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29754146
NCBI chr 2:40,178,182...40,194,932
Ensembl chr 2:40,178,177...40,194,935
G
EEF2
eukaryotic translation elongation factor 2
disease_progression
ISO
protein:increased expression:blood serum (human)
RGD
PMID:24377563
RGD:153298905
NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680
G
EGF
epidermal growth factor
treatment
ISO
RGD
PMID:25992884 PMID:26927662
RGD:13464348 RGD:13464350
NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046
G
EGFR
epidermal growth factor receptor
susceptibility ameliorates severity treatment
ISO
protein:decreased expression:tumor (human) ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma | ClinVar Annotator: match by term: Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic human cells in mouse model
RGD ClinVar
PMID:11423618 PMID:11789762 PMID:15118073 PMID:15118125 PMID:15272417 PMID:15329413 PMID:15604253 PMID:15623594 PMID:15625347 PMID:15710947 PMID:15728811 PMID:15737014 PMID:15738541 PMID:15741570 PMID:15788655 PMID:15897572 PMID:15901872 PMID:15998907 PMID:16105816 PMID:16115929 PMID:16187797 PMID:16199108 PMID:16203769 PMID:16204011 PMID:16205628 PMID:16258541 PMID:16467085 PMID:16533793 PMID:16863509 PMID:16865253 PMID:16912157 PMID:16956694 PMID:17020982 PMID:17047654 PMID:17085664 PMID:17106442 PMID:17192902 PMID:17285735 PMID:17317677 PMID:17387341 PMID:17429313 PMID:17473653 PMID:17473659 PMID:17510392 PMID:17726540 PMID:17904685 PMID:18093943 PMID:18176089 PMID:18227510 PMID:18325048 PMID:18334834 PMID:18372921 PMID:18450321 PMID:18596266 PMID:18948947 PMID:18981003 PMID:18992959 PMID:19096302 PMID:19096324 PMID:19381876 PMID:19536777 PMID:19589612 PMID:19692680 PMID:20022809 PMID:20033049 PMID:20038723 PMID:20068085 PMID:20129249 PMID:20479403 PMID:20522446 PMID:20559149 PMID:20573926 PMID:20808254 PMID:21057810 PMID:21124077 PMID:21233402 PMID:21248300 PMID:21252721 PMID:21317742 PMID:21430269 PMID:21527506 PMID:21531810 PMID:21572125 PMID:21592614 PMID:21841502 PMID:21899495 PMID:21900837 PMID:21921847 PMID:22019513 PMID:22215752 PMID:22370314 PMID:22588155 PMID:22760226 PMID:22809298 PMID:22992668 PMID:23468066 PMID:23540867 PMID:24033266 PMID:24039832 PMID:24202392 PMID:24453288 PMID:24478319 PMID:24712396 PMID:24736066 PMID:24736080 PMID:25061320 PMID:25521405 PMID:25741868 PMID:26051236 PMID:26490356 PMID:26700910 PMID:27040853 PMID:27993330 PMID:28492532 PMID:28947568 PMID:29100434 PMID:29141884 PMID:30610926 PMID:31205511 PMID:31396478 PMID:32276600 PMID:33858029 More...
RGD:126790479 RGD:13464349 RGD:151357000 RGD:153344584 RGD:5131640
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EGR1
early growth response 1
resistance
ISO
mRNA:increased expression:tumor (human)
RGD
PMID:15774784
RGD:5131925
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
treatment
ISO
human cells in mouse model
RGD
PMID:23632475
RGD:150404268
NCBI chr15:48,423,001...48,443,373
Ensembl chr15:48,422,816...48,443,399
G
EML4
EMAP like 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17625570 PMID:21757253 PMID:21767331 PMID:22568572 PMID:22617245 PMID:22986231 More...
NCBI chr 3:98,005,809...98,155,876
Ensembl chr 3:98,005,812...98,155,846
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
G
ENO2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21595568
NCBI chr 5:63,799,927...63,809,067
Ensembl chr 5:63,799,930...63,809,410
G
EPAS1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:21812995
RGD:10395382
NCBI chr 3:94,167,759...94,253,662
Ensembl chr 3:94,165,816...94,254,079
G
EPHX1
epoxide hydrolase 1
disease_progression
ISO
RGD
PMID:17273734
RGD:4889124
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:15457249 PMID:15753357 PMID:16638863 PMID:16863509 PMID:18334834 PMID:22325357 PMID:22761469 PMID:24033266 More...
NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
G
ERBB3
erb-b2 receptor tyrosine kinase 3
treatment disease_progression
ISO
RGD
PMID:11789762 PMID:20364069
RGD:126790478 RGD:126790479
NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment disease_progression severity
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:multiple (human) DNA:silent mutation:cds:p.N118N (human) protein:decreased expression:lung (human)
CTD RGD
PMID:15140544 PMID:16957145 PMID:21553054 PMID:23549037 PMID:23912706 PMID:24443257 PMID:28924235 More...
RGD:127229948 RGD:127229950 RGD:13207308 RGD:13207428 RGD:153323316
NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
disease_progression treatment
ISO
DNA:polymorphism:cds:p.K751Q(human) DNA:SNPs:multiple (human)
RGD
PMID:25596702 PMID:28924235
RGD:12880391 RGD:153323316
NCBI chr 6:51,734,318...51,757,508
Ensembl chr 6:51,734,320...51,757,553
G
ERCC3
ERCC excision repair 3, TFIIH core complex helicase subunit
treatment
ISO
DNA:snp:intron:c.2064+741T>C (rs3738948) (human)
RGD
PMID:25069034
RGD:11098167
NCBI chr15:25,189,644...25,224,381
Ensembl chr15:25,189,663...25,228,066
G
ERCC5
ERCC excision repair 5, endonuclease
treatment
ISO
DNA:SNPs:multiple (human)
RGD
PMID:24782167 PMID:28924235
RGD:151347410 RGD:153323316
NCBI chr11:71,141,823...71,168,326
Ensembl chr11:71,141,842...71,168,322
G
ERCC6
ERCC excision repair 6, chromatin remodeling factor
treatment
ISO
DNA:SNP:intron: (rs4253002) (human)
RGD
PMID:28924235
RGD:153323316
NCBI chr14:89,998,125...90,075,911
Ensembl chr14:90,002,024...90,075,898
G
ERGIC3
ERGIC and golgi 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27588471
NCBI chr17:38,884,830...38,899,140
Ensembl chr17:38,885,117...38,899,138
G
ESR1
estrogen receptor 1
ISO
DNA:hypermethylation: :lung
RGD
PMID:19506903
RGD:4892255
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
disease_progression
ISO
RGD
PMID:21539681 PMID:23300840
RGD:126781700 RGD:126781715
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
FAP
fibroblast activation protein alpha
disease_progression
ISO
RGD
PMID:29415055
RGD:152600902
NCBI chr15:68,831,281...68,902,416
Ensembl chr15:68,830,730...68,902,379
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21807637
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FAT1
FAT atypical cadherin 1
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:31085721 PMID:34390292
RGD:151347689
NCBI chr17:8,466,099...8,580,715
Ensembl chr17:8,457,187...8,580,715
G
FBXO11
F-box protein 11
treatment
ISO
RGD
PMID:31778188
RGD:152025265
NCBI chr 3:92,696,402...92,792,623
Ensembl chr 3:92,696,441...92,792,616
G
FGF9
fibroblast growth factor 9
severity
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung (human)
CTD RGD
PMID:19358281 PMID:24239165 PMID:31884893
RGD:152177524 RGD:152177912
NCBI chr11:1,554,648...1,581,938
Ensembl chr11:1,554,763...1,582,408
G
FGFR1
fibroblast growth factor receptor 1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22286583 PMID:23806793 PMID:27794399
RGD:25330355
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
FGFR4
fibroblast growth factor receptor 4
severity disease_progression
ISO
DNA:SNP:exon 9: p.G3888R (rs351855) (human) mRNA, protein:increased expression:lung (human)
RGD
PMID:23524567 PMID:26045670
RGD:150429970 RGD:150429982
NCBI chr 2:80,841,536...80,853,791
Ensembl chr 2:80,841,536...80,853,796
G
FH
fumarate hydratase
severity
ISO
DNA:SNP: (rs1414493) (human)
RGD
PMID:25576295
RGD:150340558
NCBI chr10:12,404,143...12,431,843
Ensembl chr10:12,404,176...12,431,824
G
FHIT
fragile histidine triad diadenosine triphosphatase
disease_progression
ISO
DNA:loss of heterozygosity:intron: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9635574 PMID:9850082 PMID:11788890
RGD:13792770 RGD:13792815
NCBI chr13:41,443,963...42,884,799
Ensembl chr13:41,443,965...42,392,817
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
disease_progression
ISO
protein:increased expression:lung (human)
RGD
PMID:25375657
RGD:11074609
NCBI chr 3:110,820,403...110,842,903
Ensembl chr 3:110,823,666...110,843,068
G
FOXA1
forkhead box A1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung
CTD RGD
PMID:26658322 PMID:26909612 PMID:32717239
RGD:11554787 RGD:151665747
NCBI chr 7:62,471,233...62,479,638
Ensembl chr 7:62,471,249...62,479,220
G
FOXA2
forkhead box A2
ISO
mRNA:decreased expression:lung
RGD
PMID:26658322
RGD:11554787
NCBI chr17:29,997,397...30,001,704
Ensembl chr17:29,997,401...30,001,707
G
FOXL2
forkhead box L2
ISO
DNA:hypermethylation: (human)
RGD
PMID:23599765
RGD:13503323
NCBI chr13:79,708,693...79,709,825
Ensembl chr13:79,708,693...79,709,825
G
FOXM1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18345025 PMID:19672312
NCBI chr 5:67,246,219...67,263,215
Ensembl chr 5:67,245,694...67,263,211 Ensembl chr 5:67,245,694...67,263,211
G
FOXO3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19380174
NCBI chr 1:74,626,673...74,760,323
Ensembl chr 1:74,628,218...74,760,325
G
FOXP1
forkhead box P1
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:22491060
RGD:153350086
NCBI chr13:52,346,844...52,974,358
Ensembl chr13:52,348,234...52,876,892
G
FRZB
frizzled related protein
ISO
DNA:hypermethylation:exon 1
RGD
PMID:27623992
RGD:32716395
NCBI chr15:88,332,856...88,377,275
Ensembl chr15:88,332,860...88,377,247
G
GCLC
glutamate-cysteine ligase catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,565...27,253,530
G
GIPR
gastric inhibitory polypeptide receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr 6:52,022,667...52,033,959
Ensembl chr 6:52,022,681...52,033,954
G
GNAQ
G protein subunit alpha q
disease_progression
ISO
RGD
PMID:24518087
RGD:126781753
NCBI chr 1:230,607,469...230,906,988
Ensembl chr 1:230,605,265...230,907,674
G
GPR135
G protein-coupled receptor 135
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28722770
NCBI chr 1:188,580,016...188,582,526
Ensembl chr 1:188,580,947...188,582,434
G
GPX1
glutathione peroxidase 1
treatment onset
ISO
DNA:SNP: (human) mRNA:increased expression:leukocyte (human)
RGD
PMID:19347979 PMID:33474835
RGD:152998881 RGD:152998904
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
GRIK2
glutamate ionotropic receptor kainate type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 1:68,052,086...68,680,448
Ensembl chr 1:68,057,538...68,679,256
G
GRP
gastrin releasing peptide
disease_progression
ISO
protein:increased expression:serum (human)
RGD
PMID:30146822
RGD:401700396
NCBI chr 1:161,708,815...161,721,986
Ensembl chr 1:161,708,812...161,721,782
G
HDAC3
histone deacetylase 3
ISO
RGD
PMID:24482232
RGD:9588265
NCBI chr 2:143,273,188...143,287,421
Ensembl chr 2:143,273,192...143,287,399
G
HES1
hes family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21994468
NCBI chr13:131,135,970...131,137,865
Ensembl chr13:131,135,725...131,138,237
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21812995 PMID:30381462
RGD:10395382
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
protein:increased expression:lung (human)
RGD
PMID:20716340
RGD:9999189
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
susceptibility
ISO
antibody 703D4 recognizes Hnrnpa2b1 protein (RGD:9685415);protein:increased expression:sputum (human)
RGD
PMID:2846790
RGD:9685413
NCBI chr18:46,205,164...46,215,861
Ensembl chr18:46,205,418...46,215,856
G
HRAS
HRas proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:2674130 PMID:3004741 PMID:3283542 PMID:3304147 PMID:6287572 PMID:6287573 PMID:6288698 PMID:10716188 PMID:21779495 PMID:24033266 PMID:25741868 PMID:28492532 PMID:29493581 More...
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
HS3ST2
heparan sulfate-glucosamine 3-sulfotransferase 2
ISO
DNA:hypermethylation
RGD
PMID:27777637
RGD:152998954
NCBI chr 3:23,255,936...23,366,570
Ensembl chr 3:23,255,961...23,366,351
G
HTRA1
HtrA serine peptidase 1
exacerbates
ISO
protein:decreased expression:lung (human)
RGD
PMID:32878625
RGD:152975629
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
ICAM1
intercellular adhesion molecule 1
disease_progression
ISO
progression-free survival; protein:increased secretion:serum (human)
RGD
PMID:19949019
RGD:4145465
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
DNA:SNP: (rs11540478) (human)
RGD
PMID:25576295
RGD:150340558
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
IKZF2
IKAROS family zinc finger 2
exacerbates
ISO
protein:decreased expression:venous blood, lung, regulatory T cell (human)
RGD
PMID:26460798
RGD:151347635
NCBI chr15:115,512,160...115,677,503
Ensembl chr15:115,512,179...115,677,374
G
IKZF3
IKAROS family zinc finger 3
exacerbates
ISO
protein:increased expression:lung (human)
RGD
PMID:24823637
RGD:151347636
NCBI chr12:22,466,386...22,562,320
Ensembl chr12:22,466,414...22,562,312
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20471133
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL18
interleukin 18
ISO
protein:increased expression:serum
RGD
PMID:15955140
RGD:4889836
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL1A
interleukin 1 alpha
ISO
DNA:SNPs: :
RGD
PMID:19505916
RGD:4142793
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
G
IL1RN
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:16126303
RGD:4143167
G
IL6R
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22552503
NCBI chr 4:95,322,426...95,381,393
Ensembl chr 4:95,322,433...95,381,282
G
IL7
interleukin 7
disease_progression
ISO
RGD
PMID:21159243
RGD:151347686
NCBI chr 4:57,677,895...57,744,713
Ensembl chr 4:57,684,796...57,744,709
G
IL7R
interleukin 7 receptor
disease_progression susceptibility
ISO
DNA:SNPs:: rs1494555,rs7737000(human)
RGD
PMID:19505916 PMID:21159243
RGD:151347686 RGD:4142793
NCBI chr16:21,300,141...21,330,156
Ensembl chr16:21,300,111...21,329,585
G
IQSEC1
IQ motif and Sec7 domain ArfGEF 1
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:22491060
RGD:153350086
NCBI chr13:71,203,967...71,366,685
Ensembl chr13:71,031,001...71,366,684
G
IRF1
interferon regulatory factor 1
ISO
ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:10395927
NCBI chr 2:134,776,122...134,783,646
Ensembl chr 2:134,776,129...134,783,801
G
IRS4
insulin receptor substrate 4
ISO
protein:increased expression:lung (human)
RGD
PMID:33894221
RGD:151347872
NCBI chr X:89,204,348...89,221,463
Ensembl chr X:89,204,355...89,221,085
G
ITGA9
integrin subunit alpha 9
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:22491060
RGD:153350086
NCBI chr13:22,298,497...22,655,717
Ensembl chr13:22,268,503...22,655,704
G
ITGB1
integrin subunit beta 1
ISO
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21478906 PMID:28537888
RGD:13792830
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326
G
ITGB3
integrin subunit beta 3
ISO
RGD
PMID:19386436
RGD:5037228
NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
G
ITGB4
integrin subunit beta 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27107458
NCBI chr12:5,651,292...5,685,601
Ensembl chr12:5,651,292...5,685,611
G
JAK1
Janus kinase 1
disease_progression
ISO
protein:increased phosphorylation:lung
RGD
PMID:28989534
RGD:150524360
NCBI chr 6:147,320,288...147,567,188
Ensembl chr 6:147,429,056...147,567,182
G
JAK2
Janus kinase 2
treatment
ISO
human cells in mouse model
RGD
PMID:21325979 PMID:25869210
RGD:149735332 RGD:149735342
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
severity
ISO
RNA:increased expression:lung (human)
RGD
PMID:29895215
RGD:151347665
NCBI chr 2:66,214,086...66,219,435
Ensembl chr 2:66,214,138...66,217,002
G
KAT2A
lysine acetyltransferase 2A
disease_progression
ISO
RGD
PMID:23543735
RGD:9590260
NCBI chr12:20,638,493...20,647,464
Ensembl chr12:20,638,497...20,647,461
G
KDM1A
lysine demethylase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22493729
NCBI chr 6:80,903,407...80,971,875
Ensembl chr 6:80,903,424...80,971,873
G
KDM2A
lysine demethylase 2A
severity
ISO
human gene in a mouse model mRNA:increased expression:stomach (human)
RGD
PMID:24200691 PMID:24482232
RGD:9588263 RGD:9588265
NCBI chr 2:5,238,690...5,357,799
Ensembl chr 2:5,240,312...5,357,829
G
KDM3B
lysine demethylase 3B
ISO
DNA:amplification:lung, peripheral blood mononuclear cell (human)
RGD
PMID:18975135
RGD:9586737
NCBI chr 2:140,346,145...140,418,556
Ensembl chr 2:140,346,223...140,418,527
G
KDM5A
lysine demethylase 5A
severity
ISO
protein:increased expression:lung (human)
RGD
PMID:25162518
RGD:9588530
NCBI chr 5:67,628,791...67,716,143
Ensembl chr 5:67,629,380...67,715,905
G
KDM6A
lysine demethylase 6A
exacerbates
ISO
human cells in a mouse model
RGD
PMID:32879445
RGD:150429731
NCBI chr X:39,953,764...40,154,197
Ensembl chr X:39,953,814...40,154,029
G
KDR
kinase insert domain receptor
disease_progression treatment
ISO
DNA:CNVs protein:increased expression:plasma DNA:SNP:promoter:���906T>C (rs2071559) (human) DNA, protein:CNVs, increased expression:lung
RGD
PMID:12415261 PMID:16697074 PMID:21481963 PMID:21724587 PMID:25561764 PMID:25975224 More...
RGD:126908001 RGD:126925188 RGD:126925189 RGD:126925192 RGD:126925198 RGD:126925199
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KEAP1
kelch like ECH associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22684020
NCBI chr 2:69,280,940...69,290,267
Ensembl chr 2:69,276,336...69,294,382
G
KIF5B
kinesin family member 5B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21757253
NCBI chr10:42,637,105...42,693,551
Ensembl chr10:42,637,109...42,693,491
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24688052
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
KMT2C
lysine methyltransferase 2C
disease_progression
ISO
RGD
PMID:33665490
RGD:150523771
NCBI chr18:4,993,213...5,279,668
Ensembl chr18:4,993,227...5,278,723
G
KMT2D
lysine methyltransferase 2D
disease_progression
ISO
DNA, protein:missense mutations, nonsense mutations, frameshift mutation, increased expression:lung
RGD
PMID:25112956 PMID:29627316 PMID:33665490
RGD:150523767 RGD:150523769 RGD:150523771
NCBI chr 5:15,049,827...15,091,622
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:2547513 PMID:3627975 PMID:6320174 PMID:6695174 PMID:7773929 PMID:8439212 PMID:11745231 PMID:12720172 PMID:15093544 PMID:15696205 PMID:15842656 PMID:16051643 PMID:16247081 PMID:16474404 PMID:16474405 PMID:17062680 PMID:17332249 PMID:17704260 PMID:17910045 PMID:19047918 PMID:19349489 PMID:19358724 PMID:19396835 PMID:19794967 PMID:20805368 PMID:20926413 PMID:20949522 PMID:20949621 PMID:21044336 PMID:21063026 PMID:21079152 PMID:21169357 PMID:22499344 PMID:22571758 PMID:22683711 PMID:23096712 PMID:23255105 PMID:23548132 PMID:24033266 PMID:24138715 PMID:24382853 PMID:24720724 PMID:25695684 PMID:25705018 PMID:25741868 PMID:25808193 PMID:26242988 PMID:26521233 PMID:27577878 PMID:28492532 PMID:29298116 PMID:29493581 PMID:30443000 PMID:30544177 PMID:30732632 PMID:30902772 PMID:31573083 PMID:31666701 PMID:31891627 PMID:32581362 PMID:33142350 PMID:34114335 PMID:34958143 PMID:35658005 PMID:35794233 More...
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
L1CAM
L1 cell adhesion molecule
disease_progression
ISO
RGD
PMID:22307136
RGD:11570503
NCBI chr X:124,595,649...124,618,292
Ensembl chr X:124,595,651...124,618,269
G
LAMB3
laminin subunit beta 3
ISO
mRNA:increased expression:lung:
RGD
PMID:10964684
RGD:13793368
NCBI chr 9:133,298,009...133,351,162
Ensembl chr 9:133,311,834...133,351,197
G
LAMC2
laminin subunit gamma 2
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung:
CTD RGD
PMID:10964684 PMID:26180921 PMID:30381462
RGD:13793367 RGD:13793368
NCBI chr 9:124,427,545...124,499,672
Ensembl chr 9:124,435,807...124,495,351
G
LEP
leptin
ISO
protein:increased expression:serum
RGD
PMID:19033693
RGD:5128815
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LGALS1
galectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr 5:10,149,069...10,152,514
Ensembl chr 5:10,149,068...10,156,023
G
LOC100511905
arylamine N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:18258609
RGD:4140950
NCBI chr17:13,383,478...13,393,287
G
LOC100622859
baculoviral IAP repeat-containing protein 2
exacerbates
ISO
protein:increased expression:lung (human)
RGD
PMID:27737687
RGD:152998985
NCBI chr 9:33,041,592...33,062,865
Ensembl chr 9:33,041,663...33,062,854
G
LOC100737875
solute carrier family 22 member 10-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 2:8,734,036...8,750,828
G
LOC100739508
glutathione S-transferase P-like
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (human) DNA:SNP: :p.A114V (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17094902 PMID:18258609 PMID:19174490
RGD:4140944 RGD:4140950
NCBI chr 2:5,005,498...5,009,247
G
LOC110257935
matrix-remodeling-associated protein 5-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22696596
NCBI chr Y:6,511,350...6,524,989
G
LOC110258578
interleukin-1 beta-like
susceptibility
ISO
DNA:polymorphism: :-31T>C (human)
RGD
PMID:16126303
RGD:4143167
G
LOC641352
caspase-15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22514692
NCBI chr13:24,046,127...24,068,431
G
LRP1B
LDL receptor related protein 1B
ameliorates
ISO
DNA:mutations:multiple: (human)
RGD
PMID:31164891
RGD:150429775
NCBI chr15:9,612,805...11,499,969
Ensembl chr15:9,613,238...11,499,530
G
LRRC56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:2674130 PMID:3004741 PMID:3283542 PMID:3304147 PMID:6287572 PMID:6287573 PMID:6288698 PMID:10716188 PMID:21779495 PMID:24033266 PMID:25741868 PMID:28492532 PMID:29493581 More...
NCBI chr 2:303,836...323,701
Ensembl chr 2:304,430...323,699
G
LRRC59
leucine rich repeat containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr12:26,678,207...26,694,277
Ensembl chr12:26,677,226...26,694,279
G
LTA
lymphotoxin alpha
ISO
protein:increased expression:lung
RGD
PMID:9669810
RGD:4143264
NCBI chr 7:23,696,387...23,698,280
Ensembl chr 7:23,696,040...23,698,299
G
LTF
lactotransferrin
ISO
RGD
PMID:21532506
RGD:7243860
NCBI chr13:29,413,886...29,445,751
Ensembl chr13:29,413,886...29,445,739
G
MACIR
macrophage immunometabolism regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 2:108,733,347...108,753,276
Ensembl chr 2:108,733,357...108,753,275
G
MANF
mesencephalic astrocyte derived neurotrophic factor
susceptibility
ISO
RGD
PMID:8971156
RGD:1599219
NCBI chr13:33,658,279...33,662,218
Ensembl chr13:33,658,255...33,662,261
G
MAP2K1
mitogen-activated protein kinase kinase 1
ameliorates
ISO
ClinVar Annotator: match by term: Non-small cell lung carcinoma ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma
RGD ClinVar
PMID:7651428 PMID:17704260 PMID:18060073 PMID:18632602 PMID:19411838 PMID:19915144 PMID:20301365 PMID:21514245 PMID:22327936 PMID:23444215 PMID:23569304 PMID:24033266 PMID:25049390 PMID:25157968 PMID:25741868 PMID:28492532 PMID:29643386 PMID:30763456 More...
RGD:150530476
NCBI chr 1:164,381,892...164,469,313
Ensembl chr 1:164,381,845...164,471,226
G
MAP2K2
mitogen-activated protein kinase kinase 2
ameliorates
ISO
RGD
PMID:21514245
RGD:150530476
NCBI chr 2:74,626,739...74,651,352
Ensembl chr 2:74,626,783...74,651,348
G
MAP2K4
mitogen-activated protein kinase kinase 4
ameliorates
ISO
associated with Postoperative Complications;DNA:SNP:intron: (rs12452497)(human)
RGD
PMID:26165383
RGD:11521299
NCBI chr12:56,402,029...56,516,217
Ensembl chr12:56,402,075...56,516,238
G
MAP2K7
mitogen-activated protein kinase kinase 7
susceptibility exacerbates
ISO
DNA:SNP:3' utr: (rs3679) (human)
RGD
PMID:21317887 PMID:27861856
RGD:155230827 RGD:155249848
NCBI chr 2:71,299,010...71,308,432
Ensembl chr 2:71,298,325...71,308,124
G
MAP3K1
mitogen-activated protein kinase kinase kinase 1
severity
ISO
DNA:SNPs:5'-UTR, intron 1: (rs17661089, rs16886403, rs726501) (human)
RGD
PMID:21636554
RGD:150573805
NCBI chr16:35,872,301...35,947,097
Ensembl chr16:35,872,131...35,946,987
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
disease_progression
ISO
RGD
PMID:23533274 PMID:28393206
RGD:151356965 RGD:151356978
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
disease_progression ameliorates severity
ISO
protein:increased expression:lung, cytoplasm (human) human cells in mouse model protein:increased expression:lung (human) DNA:mutations:multiple
RGD
PMID:24469836 PMID:27264345 PMID:29567880 PMID:31662324 PMID:32276600 PMID:32945371 More...
RGD:151356750 RGD:151356758 RGD:151356906 RGD:151356915 RGD:151356931 RGD:151357000
NCBI chr 4:98,562,092...98,567,014
Ensembl chr 4:98,534,812...98,567,006
G
MDM2
MDM2 proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19941079 PMID:21268124
NCBI chr 5:33,105,717...33,137,602
Ensembl chr 5:33,105,759...33,137,739
G
MEOX1
mesenchyme homeobox 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34837450
NCBI chr12:19,431,397...19,452,430
Ensembl chr12:19,431,420...19,451,993
G
MET
MET proto-oncogene, receptor tyrosine kinase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21623265 PMID:21815704 PMID:22787409 PMID:24092988 PMID:24688052
RGD:13434906
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MIER3
MIER family member 3
ISO
mRNA:decreased expression:lung
RGD
PMID:35117188
RGD:407571696
NCBI chr16:35,990,468...36,025,424
Ensembl chr16:35,990,469...36,025,436
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:12576459
RGD:4891022
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR107
microRNA mir-107
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:30280776
RGD:126925764
NCBI chr14:101,420,743...101,420,829
Ensembl chr14:101,420,743...101,420,829
G
MIR126
microRNA mir-126
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20097187
G
MIR136
microRNA mir-136
ameliorates
ISO
RNA:decreased expression:lung (human) human cells in mouse model
RGD
PMID:31059060 PMID:34556984
RGD:153344608 RGD:153344623
NCBI chr 7:121,711,328...121,711,409
Ensembl chr 7:121,711,325...121,711,414
G
MIR145
microRNA mir-145
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20097187
NCBI chr 2:150,580,126...150,580,211
Ensembl chr 2:150,580,126...150,580,211
G
MIR193A
microRNA mir-193a
ameliorates
ISO
miRNA:decreased expression:lung (human) human cells in mouse model
RGD
PMID:26655272 PMID:31205511
RGD:11085320 RGD:153344584
NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048
G
MIR205
microRNA mir-205
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21563230
NCBI chr 9:133,517,078...133,517,146
Ensembl chr 9:133,517,078...133,517,146
G
MIR21
microRNA mir-21
disease_progression
ISO
RNA:increased expression:blood serum (human) RNA:increased expression:lung (human)
RGD
PMID:20223231 PMID:20956945 PMID:22956424 PMID:25477028 PMID:26880855 PMID:33467964 More...
RGD:152998885 RGD:152998886 RGD:152998889 RGD:152998899 RGD:152998901 RGD:41404697
NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
G
MIR222
microRNA mir-222
disease_progression
ISO
RGD
PMID:24955421 PMID:30233216
RGD:151708732 RGD:151708743
NCBI chr X:40,571,808...40,571,887
Ensembl chr X:40,571,808...40,571,887
G
MIR29A
microRNA mir-29a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22048643
NCBI chr18:18,040,032...18,040,117
Ensembl chr18:18,040,032...18,040,118
G
MIR29B-1
microRNA mir-29b-1
treatment
ISO
RGD
PMID:23591808
RGD:13464324
NCBI chr18:18,039,629...18,039,709
Ensembl chr18:18,039,629...18,039,709
G
MIR30C-1
microRNA mir-30c-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20889907
NCBI chr 6:170,426,781...170,426,860
Ensembl chr 6:170,426,781...170,426,860
G
MIR31
microRNA mir-31
ISO
miRNA:increased expression:sputum (human)
RGD
PMID:27777637
RGD:152998954
NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809
G
MIR381
microRNA mir-381
treatment
ISO
RGD
PMID:29287202
RGD:13464271
G
MIR497
microRNA mir-497
ISO
miRNA:decreased expression:lung
RGD
PMID:31115562
RGD:126925181
NCBI chr12:52,422,329...52,422,408
Ensembl chr12:52,422,330...52,422,411
G
MIR671
microRNA mir-671
severity
ISO
RGD
PMID:30664171
RGD:151665171
NCBI chr18:5,989,378...5,989,457
Ensembl chr18:5,989,355...5,989,466
G
MKI67
marker of proliferation Ki-67
ameliorates
ISO
human cells in mouse model
RGD
PMID:31205511 PMID:32276600
RGD:151357000 RGD:153344584
NCBI chr14:137,266,622...137,296,312
G
MLH1
mutL homolog 1
severity
ISO
RGD
PMID:18370958 PMID:32211850
RGD:126848780 RGD:126848801
NCBI chr13:21,791,276...21,877,789
Ensembl chr13:21,791,203...21,877,757
G
MMP1
matrix metallopeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20471133
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
MMP11
matrix metallopeptidase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10741738
NCBI chr14:49,907,684...49,917,494
Ensembl chr14:49,907,687...49,912,617
G
MMP2
matrix metallopeptidase 2
severity
ISO
protein:increased expression, increased activity:lung
RGD
PMID:17143501
RGD:5130739
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP7
matrix metallopeptidase 7
ISO
mRNA:increased expression:lung
RGD
PMID:19596921
RGD:5129528
NCBI chr 9:33,214,590...33,225,080
Ensembl chr 9:33,214,594...33,225,080
G
MMP9
matrix metallopeptidase 9
disease_progression
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20704821 PMID:21789004
RGD:5129215
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MS4A1
membrane spanning 4-domains A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22514692
NCBI chr 2:11,216,238...11,229,060
Ensembl chr 2:11,215,901...11,222,914
G
MSH2
mutS homolog 2
treatment
ISO
protein:decreased expression:lung DNA:SNP: :rs6544991 (human)
RGD
PMID:16783774 PMID:20145178 PMID:20458443 PMID:28093084 PMID:32211850
RGD:126848780 RGD:126848786 RGD:126848789 RGD:126848791 RGD:126848800
NCBI chr 3:93,082,958...93,163,556
Ensembl chr 3:93,081,219...93,163,585
G
MSH3
mutS homolog 3
treatment
ISO
DNA:SNPs: :rs6151627, rs6151670, rs7709909 (human)
RGD
PMID:28093084
RGD:126848786
NCBI chr 2:89,255,647...89,456,102
Ensembl chr 2:89,250,003...89,453,936
G
MSH5
mutS homolog 5
treatment
ISO
DNA:SNPs: :rs805304, rs707939 (human)
RGD
PMID:28093084
RGD:126848786
NCBI chr 7:23,852,864...23,872,760
Ensembl chr 7:23,852,918...23,872,760
G
MT3
metallothionein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr 6:18,634,735...18,636,134
Ensembl chr 6:18,634,261...18,636,131
G
MTOR
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24688052
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
MYD88
MYD88 innate immune signal transduction adaptor
disease_progression
ISO
protein:increased expression:lung (human) DNA:hypomethylation:promoter (human)
RGD
PMID:31432177 PMID:32010578
RGD:150519919 RGD:150524328
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
NCAPH
non-SMC condensin I complex subunit H
ISO
protein:decreased expression:lung (human)
RGD
PMID:32945371
RGD:151356931
NCBI chr 3:46,852,388...46,893,008
Ensembl chr 3:46,852,392...46,893,013
G
NCOA2
nuclear receptor coactivator 2
ISO
DNA:SNPs:introns: (rs2926702, rs11993276) (human)
RGD
PMID:23144319
RGD:153002581
NCBI chr 4:64,888,029...65,245,757
Ensembl chr 4:64,954,238...65,246,572
G
NCOA3
nuclear receptor coactivator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20852035
NCBI chr17:49,528,275...49,660,471
Ensembl chr17:49,528,179...49,663,200
G
NDC80
NDC80 kinetochore complex component
disease_progression
ISO
RGD
PMID:17079454
RGD:28867236
NCBI chr 6:104,000,794...104,055,785
Ensembl chr 6:103,999,034...104,055,760
G
NDRG1
N-myc downstream regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341671
NCBI chr 4:8,014,445...8,069,335
Ensembl chr 4:8,014,446...8,069,335
G
NEK2
NIMA related kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28509438
NCBI chr 9:131,547,044...131,560,527
Ensembl chr 9:131,547,069...131,561,095
G
NF1
neurofibromin 1
ISO
mRNA:increased expression:lung (human)
RGD
PMID:30280776
RGD:126925764
NCBI chr12:43,487,098...43,754,205
Ensembl chr12:43,489,813...43,753,969
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
ISO
RGD
PMID:21743150
RGD:150530639
NCBI chr14:46,653,869...46,726,421
Ensembl chr14:46,653,900...46,731,999
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22684020 PMID:26482881 PMID:33148531
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NFKB1
nuclear factor kappa B subunit 1
susceptibility
ISO
DNA:polymorphism:rs28362491(human) protein:increased expression:nucleus
RGD
PMID:17899287 PMID:26221384
RGD:13793390 RGD:13793391
NCBI chr 8:118,391,010...118,478,927
Ensembl chr 8:118,390,638...118,506,691
G
NNAT
neuronatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr17:40,625,990...40,629,523
G
NOTCH3
notch receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21994468
NCBI chr 2:62,364,507...62,402,348
Ensembl chr 2:62,364,501...62,402,344
G
NQO1
NAD(P)H quinone dehydrogenase 1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:cds: 609 C>T (human) DNA:polymorphism: :
CTD RGD
PMID:9865924 PMID:19596483 PMID:21479364
RGD:5133265 RGD:5133268
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
NR3C1
nuclear receptor subfamily 3 group C member 1
disease_progression
ISO
protein:increased expression:lung
RGD
PMID:16806572
RGD:4892333
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
G
NRAS
NRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:1654209 PMID:6587382 PMID:12727991 PMID:14508525 PMID:18633438 PMID:19880792 PMID:22499344 PMID:22773810 PMID:23392294 PMID:24006476 PMID:24033266 PMID:25741868 More...
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
NRP1
neuropilin 1
disease_progression
ISO
DNA, protein:CNVs, increased expression:lung
RGD
PMID:25561764
RGD:126925188
NCBI chr10:56,280,673...56,430,832
Ensembl chr10:56,280,665...56,430,777
G
NSD2
nuclear receptor binding SET domain protein 2
ISO
mRNA:increased expression:lung (human)
RGD
PMID:34551195
RGD:155663369
NCBI chr 8:938,832...1,018,032
Ensembl chr 8:964,893...1,018,028
G
NUF2
NUF2 component of NDC80 kinetochore complex
disease_progression
ISO
RGD
PMID:17079454
RGD:28867236
NCBI chr 4:87,162,873...87,194,193
Ensembl chr 4:87,162,818...87,194,170
G
OSMR
oncostatin M receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr16:24,041,312...24,101,842
Ensembl chr16:24,041,567...24,102,177
G
OXTR
oxytocin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043644
NCBI chr13:65,134,055...65,155,543
Ensembl chr13:65,134,057...65,153,487
G
PAOX
polyamine oxidase
susceptibility
ISO
DNA:SNPs: :rs7316, rs1046175(human)
RGD
PMID:31016788
RGD:151667418
NCBI chr14:141,360,509...141,369,642
Ensembl chr14:141,360,608...141,369,641
G
PBRM1
polybromo 1
disease_progression
ISO
RGD
PMID:32195359
RGD:150340625
NCBI chr13:34,689,718...34,821,117
Ensembl chr13:34,689,726...34,820,952
G
PDPK1
3-phosphoinositide dependent protein kinase 1
disease_progression
ISO
mRNA:increased expression:blood serum
RGD
PMID:25064732
RGD:13503320
NCBI chr 3:39,429,928...39,512,623
Ensembl chr 3:39,432,058...39,512,601
G
PECAM1
platelet and endothelial cell adhesion molecule 1
treatment
ISO
human cells in mouse model
RGD
PMID:23632475
RGD:150404268
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PGAM1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr14:108,822,782...108,832,818
Ensembl chr14:108,822,812...108,833,058
G
PHGDH
phosphoglycerate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482881
NCBI chr 4:101,445,977...101,478,144
Ensembl chr 4:101,444,693...101,478,144
G
PHLDA2
pleckstrin homology like domain family A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr 2:2,057,679...2,058,675
Ensembl chr 2:2,057,681...2,058,694
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Non-small cell lung cancer | ClinVar Annotator: match by term: Non-small cell lung carcinoma
ClinVar
PMID:15016963 PMID:15520168 PMID:15608678 PMID:15930273 PMID:17376864 PMID:17673550 PMID:20593314 PMID:21078999 PMID:22120714 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23946963 PMID:24033266 PMID:24782230 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26266975 PMID:26266985 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:29446767 PMID:29661094 PMID:29988677 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:33054853 PMID:34008892 PMID:34496175 PMID:35483878 PMID:37667289 PMID:37712948 More...
NCBI chr13:117,193,935...117,282,151
Ensembl chr13:117,180,544...117,274,587
G
PLAU
plasminogen activator, urokinase
ISO
RGD
PMID:20937265
RGD:4892055
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
G
PLBD1
phospholipase B domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr 5:57,950,872...58,022,059
Ensembl chr 5:57,948,779...58,022,058
G
PLCG1
phospholipase C gamma 1
treatment
ISO
human cell line in a mouse model
RGD
PMID:33928024
RGD:151665816
NCBI chr17:43,810,003...43,844,553
Ensembl chr17:43,810,048...43,844,554
G
POLE
DNA polymerase epsilon, catalytic subunit
ameliorates
ISO
DNA:mutations:multiple (human)
RGD
PMID:32433714
RGD:151347639
NCBI chr14:22,798,146...22,852,818
Ensembl chr14:22,798,192...22,853,547
G
PPIA
peptidylprolyl isomerase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr18:50,563,130...50,566,857
G
PRAME
PRAME nuclear receptor transcriptional regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16179254
NCBI chr14:48,901,097...48,906,855
Ensembl chr14:48,899,343...48,911,231
G
PRDM14
PR/SET domain 14
disease_progression
ISO
DNA:hypermethylation
RGD
PMID:23690269 PMID:27777637
RGD:150530468 RGD:152998954
NCBI chr 4:65,273,988...65,295,362
Ensembl chr 4:65,271,315...65,295,178
G
PRDX1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr 6:165,847,390...165,859,918
Ensembl chr 6:165,824,395...165,861,442
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31711559
RGD:151665187
NCBI chr 4:66,712,412...66,996,258
Ensembl chr 4:66,715,237...66,996,044
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
treatment
ISO
human cells in mouse model
RGD
PMID:23632475
RGD:150404268
NCBI chr16:25,745,902...25,783,524
Ensembl chr16:25,745,324...25,783,707
G
PRKCB
protein kinase C beta
ISO
DNA:hypermethylation:promoter:lung
RGD
PMID:28422739
RGD:13503321
NCBI chr 3:21,995,227...22,383,628
Ensembl chr 3:21,995,231...22,383,264
G
PRR13
proline rich 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21157449
NCBI chr 5:18,660,814...18,665,926
Ensembl chr 5:18,660,814...18,665,925
G
PSAT1
phosphoserine aminotransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482881
NCBI chr 1:231,142,673...231,172,364
Ensembl chr 1:231,142,625...231,172,360
G
PTEN
phosphatase and tensin homolog
ISO
mRNA:decreased expression:lung (human) DNA:loss of heterozygosity:cds: (human)
RGD
PMID:9458098 PMID:20223231 PMID:22956424
RGD:12832745 RGD:152998889 RGD:152998901
NCBI chr14:99,929,590...100,021,619
G
PTGES
prostaglandin E synthase
severity
ISO
protein:increased expression:lung
RGD
PMID:20592629
RGD:5135302
NCBI chr 1:269,911,785...269,924,481
Ensembl chr 1:269,911,789...269,924,462
G
PTGIS
prostaglandin I2 synthase
severity
ISO
protein:decreased expression:lung (human)
RGD
PMID:16314486
RGD:151347842
NCBI chr17:51,153,151...51,200,515
Ensembl chr17:51,153,154...51,200,300
G
PTGS2
prostaglandin-endoperoxide synthase 2
severity
ISO
protein:increased expression:lung DNA:SNP: :929G>C(human)
RGD
PMID:20016751 PMID:20592629
RGD:5135302 RGD:5135471
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTHLH
parathyroid hormone like hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17676588
NCBI chr 5:45,750,968...45,763,421
Ensembl chr 5:45,751,292...45,763,415
G
PTPRB
protein tyrosine phosphatase receptor type B
disease_progression
ISO
mRNA:decreased expression:lung (human) human cells in mouse model
RGD
PMID:27314562
RGD:151361281
NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289
G
PXN
paxillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21159652
NCBI chr14:40,227,894...40,278,785
Ensembl chr14:40,227,895...40,278,734
G
PYCARD
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16778195
NCBI chr 3:17,305,921...17,307,521
Ensembl chr 3:17,306,099...17,307,786
G
RAD21
RAD21 cohesin complex component
exacerbates susceptibility
ISO
mRNA:increased expression:lung (human) DNA:SNP:intron: (rs1374297) (human)
RGD
PMID:28977903 PMID:32178590
RGD:150520031 RGD:150520036
NCBI chr 4:21,772,821...21,802,453
Ensembl chr 4:21,772,855...21,802,715
G
RAD52
RAD52 homolog, DNA repair protein
susceptibility
ISO
DNA:SNPs,haplotype:multiple
RGD
PMID:32401173
RGD:151660355
NCBI chr 5:68,140,846...68,223,587
Ensembl chr 5:68,143,646...68,169,670
G
RAF1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16862215
NCBI chr13:68,581,128...68,657,911
Ensembl chr13:68,580,812...68,657,829
G
RARB
retinoic acid receptor beta
ISO
DNA:hypermethylation:lung
RGD
PMID:18349282 PMID:23599765
RGD:13503323 RGD:13503324
NCBI chr13:12,336,387...12,507,688
Ensembl chr13:12,336,972...12,507,680
G
RASSF1
Ras association domain family member 1
ISO
CTD Direct Evidence: marker/mechanism DNA:hypermethylation
CTD RGD
PMID:18337602 PMID:27777637
RGD:152998954
NCBI chr13:32,816,156...32,825,486
Ensembl chr13:32,816,156...32,825,226
G
RASSF5
Ras association domain family member 5
ISO
RGD
PMID:20434789
RGD:13503325
NCBI chr 9:67,157,167...67,237,366
Ensembl chr 9:67,157,167...67,237,365
G
RB1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16862215
NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
G
RBM7
RNA binding motif protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15496427
NCBI chr 9:41,947,081...41,955,683
Ensembl chr 9:41,947,589...41,956,210
G
RECK
reversion inducing cysteine rich protein with kazal motifs
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17233834
NCBI chr 1:236,821,243...236,898,280
Ensembl chr 1:236,821,414...236,898,276
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16287968
RGD:2298765
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RHEB
Ras homolog, mTORC1 binding
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20554106
NCBI chr18:5,779,439...5,821,839
Ensembl chr18:5,779,212...5,822,257
G
RNF168
ring finger protein 168
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34873829
NCBI chr13:133,625,534...133,659,253
G
ROBO1
roundabout guidance receptor 1
ISO
mRNA:altered expression:lung
RGD
PMID:15264215
RGD:2314868
NCBI chr13:175,348,223...176,479,482
Ensembl chr13:175,348,410...176,479,481
G
ROS1
ROS proto-oncogene 1, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22215748 PMID:22585869 PMID:22617245 PMID:22919003
NCBI chr 1:44,409,877...44,535,784
Ensembl chr 1:44,410,351...44,534,874
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17195088
NCBI chr 6:27,601,692...27,605,127
Ensembl chr 6:27,601,695...27,605,083
G
RRM1
ribonucleotide reductase catalytic subunit M1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19002265 PMID:21496433
RGD:127229933
NCBI chr 9:6,026,151...6,065,211
Ensembl chr 9:6,025,073...6,065,143
G
RRM2
ribonucleotide reductase regulatory subunit M2
treatment
ISO
RGD
PMID:19002265
RGD:127229933
NCBI chr 3:126,357,198...126,367,145
Ensembl chr 3:126,347,819...126,365,644
G
RUNX1
RUNX family transcription factor 1
disease_progression
ISO
mRNA:alternative form:lung
RGD
PMID:26685324
RGD:126779572
NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
G
RUNX2
RUNX family transcription factor 2
ISO
human cells in mouse model
RGD
PMID:30780105
RGD:152995466
NCBI chr 7:40,106,581...40,353,304
Ensembl chr 7:40,106,532...40,460,687
G
RUNX3
RUNX family transcription factor 3
ISO
DNA:hypermethylation:promoter
RGD
PMID:18349282
RGD:13503324
NCBI chr 6:82,531,203...82,595,044
Ensembl chr 6:82,531,559...82,595,026
G
RXRG
retinoid X receptor gamma
ISO
DNA:hypermethylation:promoter
RGD
PMID:20113835
RGD:13503326
NCBI chr 4:85,158,313...85,357,116
Ensembl chr 4:85,308,508...85,357,137
G
SCGB3A2
secretoglobin family 3A member 2
ISO
RGD
PMID:20466451
RGD:5147390
NCBI chr 2:149,120,652...149,124,614
Ensembl chr 2:149,068,946...149,124,983
G
SDC4
syndecan 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22919003
NCBI chr17:47,650,387...47,670,499
G
SDHA
succinate dehydrogenase complex flavoprotein subunit A
susceptibility
ISO
DNA:SNP: 3'utr (rs13173911) (human)
RGD
PMID:25576295
RGD:150340558
NCBI chr16:79,838,442...79,862,956
Ensembl chr16:79,834,044...79,862,524
G
SDHC
succinate dehydrogenase complex subunit C
exacerbates
ISO
DNA:SNP: 3'utr (rs12064957) (human)
RGD
PMID:25576295
RGD:150340558
NCBI chr 4:89,135,410...89,169,164
Ensembl chr 4:89,130,379...89,169,118
G
SELENOS
selenoprotein S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20471133
NCBI chr 1:139,829,002...139,836,923
Ensembl chr 1:139,828,791...139,836,914
G
SERPINF1
serpin family F member 1
ISO
protein:increased expression:serum, pleural effusion (human)
RGD
PMID:20230924
RGD:27226710
NCBI chr12:47,949,004...47,959,471
Ensembl chr12:47,948,510...47,959,470
G
SFTPB
surfactant protein B
susceptibility
ISO
DNA:SNPs: :rs7316, rs9752 (human)
RGD
PMID:31016788
RGD:151667418
NCBI chr 3:59,101,940...59,113,442
Ensembl chr 3:59,101,981...59,112,396
G
SFTPD
surfactant protein D
disease_progression
ISO
RGD
PMID:20401612
RGD:4143490
NCBI chr14:82,051,400...82,069,258
Ensembl chr14:82,051,451...82,067,976
G
SHMT2
serine hydroxymethyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482881
NCBI chr 5:22,535,780...22,540,322
Ensembl chr 5:22,532,894...22,540,319
G
SLC22A18
solute carrier family 22 member 18
disease_progression
ISO
protein:increased expression:lung (human) mRNA:increased expression:lung (human)
RGD
PMID:22237119 PMID:25498886
RGD:150557424 RGD:150557425
NCBI chr 2:2,032,370...2,055,756
Ensembl chr 2:2,028,396...2,055,750
G
SLC34A2
solute carrier family 34 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617245 PMID:22919003
NCBI chr 8:19,481,127...19,507,903
Ensembl chr 8:19,481,198...19,509,666
G
SLC3A2
solute carrier family 3 member 2
disease_progression severity sexual_dimorphism
ISO
DNA:SNP:5'utr: (rs105929) (human) protein:increased expression:lung (human)
RGD
PMID:22110199 PMID:24782339 PMID:25084765
RGD:151361206 RGD:152995442 RGD:152995443
NCBI chr 2:8,892,071...8,919,070
Ensembl chr 2:8,892,089...8,919,072
G
SLC7A5
solute carrier family 7 member 5
disease_progression treatment
ISO
RGD
PMID:21187458 PMID:22110199
RGD:151361159 RGD:151361206
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
SMAD3
SMAD family member 3
ISO
protein:increased expression:lung (human)
RGD
PMID:25375657
RGD:11074609
NCBI chr 1:164,998,457...165,124,455
Ensembl chr 1:164,998,103...165,124,449
G
SMARCA4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
ISO
RGD
PMID:15287030
RGD:2302526
NCBI chr 2:69,717,175...69,810,301
Ensembl chr 2:69,662,238...69,810,295
G
SNAP47
synaptosome associated protein 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34664776
NCBI chr 2:50,812,309...50,921,744
G
SOCS1
suppressor of cytokine signaling 1
disease_progression
ISO
RGD
PMID:31910343
RGD:150573699
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11731445 PMID:17094902
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
SOX30
SRY-box transcription factor 30
disease_progression
ISO
RGD
PMID:32443323
RGD:151660331
NCBI chr16:65,642,107...65,677,693
Ensembl chr16:65,642,223...65,678,047
G
SOX4
SRY-box transcription factor 4
severity
ISO
RGD
PMID:16052521
RGD:153297793
NCBI chr 7:16,886,834...16,895,488
Ensembl chr 7:16,891,319...16,892,752
G
SPOP
speckle type BTB/POZ protein
ameliorates
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:28927035
RGD:153298923
NCBI chr12:25,792,621...25,860,630
Ensembl chr12:25,792,630...25,860,595
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:16533775
RGD:1581361
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SRSF1
serine and arginine rich splicing factor 1
severity
ISO
protein:increased expression:lung (human)
RGD
PMID:20682707 PMID:23071587
RGD:11038729 RGD:150429662
NCBI chr12:34,278,363...34,282,164
Ensembl chr12:34,272,956...34,282,162
G
SRSF2
serine and arginine rich splicing factor 2
ISO
protein:increased expression:lung epithelium,nucleus
RGD
PMID:23071587
RGD:150429662
NCBI chr12:4,800,578...4,803,767
Ensembl chr12:4,800,624...4,801,675
G
STAT3
signal transducer and activator of transcription 3
severity
ISO
CTD Direct Evidence: marker/mechanism protein:increased phosphorylation:lung (human)
CTD RGD
PMID:21549414 PMID:22977534
RGD:152023747
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STAT5B
signal transducer and activator of transcription 5B
disease_progression
ISO
mRNA,protein:increased expression:lung (human)
RGD
PMID:25137041
RGD:153298930
NCBI chr12:20,498,103...20,574,365
Ensembl chr12:20,508,404...20,574,266
G
STIM1
stromal interaction molecule 1
ISO
mRNA:increased expression:blood plasma (human)
RGD
PMID:32184656
RGD:152995359
NCBI chr 9:6,066,612...6,270,090
Ensembl chr 9:6,066,617...6,270,575
G
SYP
synaptophysin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21595568
NCBI chr X:43,232,190...43,246,764
Ensembl chr X:43,232,192...43,246,680
G
TAB2
TGF-beta activated kinase 1 (MAP3K7) binding protein 2
ISO
mRNA:increased expression:lung (human)
RGD
PMID:34551195
RGD:155663369
NCBI chr 1:16,533,364...16,611,879
Ensembl chr 1:16,533,285...16,611,884
G
TENT5A
terminal nucleotidyltransferase 5A
susceptibility
ISO
DNA:repeats: :
RGD
PMID:25884493
RGD:14390136
NCBI chr 1:84,545,033...84,552,138
Ensembl chr 1:84,545,202...84,552,134
G
TERT
telomerase reverse transcriptase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :rs2853669,rs2736108(human) DNA:SNP: :rs2736098(human)
CTD RGD
PMID:21252717 PMID:24679952 PMID:27982019
RGD:150530632 RGD:150530644
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TES
testin LIM domain protein
ameliorates
ISO
RGD
PMID:28000866
RGD:597621667
NCBI chr18:29,895,878...29,936,248
Ensembl chr18:29,895,882...29,936,233
G
TET2
tet methylcytosine dioxygenase 2
ISO
DNA:mutations:multiple
RGD
PMID:32554069
RGD:150429694
NCBI chr 8:116,413,253...116,546,976
Ensembl chr 8:116,415,267...116,545,299
G
TGFA
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16230376
NCBI chr 3:71,948,232...72,054,257
Ensembl chr 3:71,948,137...72,050,474
G
THBD
thrombomodulin
disease_progression
ISO
RGD
PMID:20607726
RGD:5685035
NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
G
TIMP3
TIMP metallopeptidase inhibitor 3
disease_progression
ISO
RGD
PMID:30233216
RGD:151708743
NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581
G
TK1
thymidine kinase 1
ISO
protein:increased expression:serum (human)
RGD
PMID:15583816
RGD:2317237
NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917
G
TLR9
toll like receptor 9
ISO
mRNA, protein:increased expression:tumor (human)
RGD
PMID:15631627
RGD:5130185
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
G
TMEM135
transmembrane protein 135
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 9:20,741,085...21,020,899
Ensembl chr 9:20,721,991...21,021,130
G
TNF
tumor necrosis factor
ISO
protein:increased expression:lung DNA:SNPs: :
RGD
PMID:9669810 PMID:19505916
RGD:4142793 RGD:4143264
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
TNFRSF1A
TNF receptor superfamily member 1A
severity disease_progression
ISO
DNA:snp:5' utr:g.-329G>T rs4149570 (human) protein:increased expression:serum (human)
RGD
PMID:20422457 PMID:20824709
RGD:5131156 RGD:5131202
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
TP53
tumor protein p53
treatment
ISO
CTD Direct Evidence: marker/mechanism human cells in mouse model
CTD RGD
PMID:17290066 PMID:23435014 PMID:23632475 PMID:24688052 PMID:30381462
RGD:150404268
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TP53BP1
tumor protein p53 binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 1:127,958,500...128,032,370
Ensembl chr 1:127,959,213...128,028,712
G
TP73
tumor protein p73
treatment
ISO
DNA:SNP:intron: (rs3765701) (human)
RGD
PMID:21965272
RGD:151347589
NCBI chr 6:65,169,770...65,228,997
Ensembl chr 6:65,182,456...65,228,990
G
TRMT11
tRNA methyltransferase 11 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 1:36,930,857...37,002,079
Ensembl chr 1:36,940,334...37,002,056
G
TTR
transthyretin
disease_progression
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:31031974
RGD:151664739
NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
exacerbates
ISO
circRNA:decreased expression:lung (human)
RGD
PMID:29944885
RGD:151665198
NCBI chr 4:34,645,794...34,794,510
Ensembl chr 4:34,645,809...34,793,940
G
UCHL1
ubiquitin C-terminal hydrolase L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17094902
NCBI chr 8:32,353,766...32,367,288
Ensembl chr 8:32,353,246...32,367,332
G
VEGFA
vascular endothelial growth factor A
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:inctreased expression:lung (human) protein:increased expression:plasma
CTD RGD
PMID:15956251 PMID:21481963 PMID:22977534
RGD:126925199 RGD:152023747
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
WEE1
WEE1 G2 checkpoint kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34664776
NCBI chr 2:49,880,416...49,894,509
Ensembl chr 2:49,880,435...49,894,499
G
WRAP53
WD repeat containing antisense to TP53
disease_progression
ISO
RNA:increased expression:lung DNA:hypermethylation:promoter
RGD
PMID:30344734 PMID:31281482
RGD:21081513 RGD:21081519
NCBI chr12:52,954,674...52,968,371
Ensembl chr12:52,954,669...52,968,364
G
XPC
XPC complex subunit, DNA damage recognition and repair factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27777383
NCBI chr13:70,348,841...70,397,194
Ensembl chr13:70,348,864...70,397,772
G
XPO1
exportin 1
ameliorates treatment
ISO
human cell line in a mouse model
RGD
PMID:24946002 PMID:31113936
RGD:151665798 RGD:151667438
NCBI chr 3:80,255,016...80,300,260
Ensembl chr 3:80,255,146...80,300,327
G
XPO5
exportin 5
severity
ISO
DNA:snp, haplotype:3' utr:c.*659A>C (rs11077) (human)
RGD
PMID:21799879
RGD:11041736
NCBI chr 7:38,530,704...38,569,558
Ensembl chr 7:38,531,919...38,569,582
G
XRCC1
X-ray repair cross complementing 1
treatment severity susceptibility
ISO
DNA:missense mutation:p.R399Q (human) DNA:SNP:3'utr: (rs25487) (human) DNA:missense mutation:cds: p.R194W (human) DNA:missense mutations:cds:p.R194W, p.R399Q (human)
RGD
PMID:15301704 PMID:19157633 PMID:19958624 PMID:22152690 PMID:23549037 PMID:24446315 PMID:24782167 PMID:25308691 PMID:26097609 PMID:26345972 More...
RGD:11097268 RGD:11251107 RGD:11538163 RGD:127229950 RGD:151232295 RGD:151232297 RGD:151347175 RGD:151347402 RGD:151347410 RGD:151347427
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
G
ZFHX3
zinc finger homeobox 3
exacerbates ameliorates
ISO
mRNA:decreased expression:lung (human) DNA:mutations:multiple (human)
RGD
PMID:23144151 PMID:32653938
RGD:151361163 RGD:151361164
NCBI chr 6:15,693,987...15,941,301
Ensembl chr 6:15,698,199...15,863,270
G
ZNF462
zinc finger protein 462
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29059373
NCBI chr 1:248,029,136...248,181,792
Ensembl chr 1:248,031,631...248,179,784
G
ZSCAN31
zinc finger and SCAN domain containing 31
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28722770
NCBI chr 7:22,173,459...22,181,784
Ensembl chr 7:22,173,457...22,181,192
G
ALX4
ALX homeobox 4
ameliorates
ISO
RGD
PMID:24037716
RGD:153344522
NCBI chr 2:18,070,726...18,085,685
Ensembl chr 2:18,037,401...18,085,683
G
CCND1
cyclin D1
ISO
protein:increased expression:lung
RGD
PMID:14674039
RGD:13434930
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
DNMT1
DNA methyltransferase 1
disease_progression
ISO
RGD
PMID:19484794
RGD:4140940
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
G
EGFR
epidermal growth factor receptor
ISO
DNA:mutations:exons: protein:increased expression:tumor (human) DNA:snp:cds:p.T790M (human)
RGD
PMID:15737014 PMID:21419590 PMID:26059825
RGD:11075076 RGD:5131465 RGD:5131630
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EGR1
early growth response 1
ISO
mRNA:decreased expression:tumor (human)
RGD
PMID:11948124
RGD:5131942
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
KRAS
KRAS proto-oncogene, GTPase
ISO
DNA:mutations:cds:
RGD
PMID:26059825
RGD:11075076
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LOC100739508
glutathione S-transferase P-like
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:19484794
RGD:4140940
NCBI chr 2:5,005,498...5,009,247
G
MIR130A
microRNA mir-130a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25926378
NCBI chr 2:13,296,695...13,296,773
Ensembl chr 2:13,296,695...13,296,773
G
MIR144
microRNA mir-144
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25926378
NCBI chr12:45,088,958...45,089,033
Ensembl chr12:45,088,959...45,089,035
G
MIR19A
microRNA mir-19a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25926378
NCBI chr11:60,734,939...60,735,020
Ensembl chr11:60,734,939...60,735,020
G
MIR345-1
microRNA mir-345-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25926378
NCBI chr 7:121,193,720...121,193,799
Ensembl chr 7:121,193,716...121,193,799
G
MIR497
microRNA mir-497
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25926378
NCBI chr12:52,422,329...52,422,408
Ensembl chr12:52,422,330...52,422,411
G
TP53
tumor protein p53
ISO
DNA:mutations:exons:
RGD
PMID:26059825
RGD:11075076
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:18440724
RGD:151361285
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
ABCE1
ATP binding cassette subfamily E member 1
severity
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:18788636
RGD:11046260
NCBI chr 8:83,302,055...83,353,208
Ensembl chr 8:83,299,322...83,353,109
G
ACSL4
acyl-CoA synthetase long chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:89,760,863...89,838,103
Ensembl chr X:89,760,866...89,806,274
G
ADAM19
ADAM metallopeptidase domain 19
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr16:65,715,445...65,814,761
Ensembl chr16:65,715,517...65,814,758
G
ADAM28
ADAM metallopeptidase domain 28
exacerbates disease_progression treatment
ISO
protein:increased expression:lung
RGD
PMID:20112342 PMID:26800504 PMID:29882245 PMID:30190423
RGD:11531771 RGD:153297792 RGD:153297794 RGD:153297795
NCBI chr14:8,375,169...8,438,622
Ensembl chr14:8,375,212...8,438,615
G
ADAMTSL3
ADAMTS like 3
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 7:51,006,356...51,363,855
Ensembl chr 7:51,006,366...51,363,620
G
ADGRG6
adhesion G protein-coupled receptor G6
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 1:22,662,009...22,802,166
Ensembl chr 1:22,662,022...22,801,848
G
AHCY
adenosylhomocysteinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr17:37,726,084...37,744,378
Ensembl chr17:37,726,084...37,744,461
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12597446
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
G
AKR1A1
aldo-keto reductase family 1 member A1
disease_progression
ISO
RGD
PMID:30727821
RGD:27226687
NCBI chr 6:165,811,245...165,825,168
Ensembl chr 6:165,811,247...165,824,896
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ALDH18A1
aldehyde dehydrogenase 18 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:107,174,062...107,221,373
Ensembl chr14:107,170,689...107,221,215
G
ALDOA
aldolase, fructose-bisphosphate A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 3:18,246,036...18,260,167
Ensembl chr 3:18,253,384...18,260,163
G
ALK
ALK receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 3:109,411,146...110,105,755
G
ALOX12B
arachidonate 12-lipoxygenase, 12R type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30258081
NCBI chr12:53,292,530...53,302,850
Ensembl chr12:53,292,526...53,302,993
G
ALOX5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30258081
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
G
ALX1
ALX homeobox 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 5:96,761,683...96,785,125
Ensembl chr 5:96,763,685...96,785,165
G
ALX4
ALX homeobox 4
disease_progression
ISO
RGD
PMID:18978557
RGD:153350135
NCBI chr 2:18,070,726...18,085,685
Ensembl chr 2:18,037,401...18,085,683
G
ANAPC2
anaphase promoting complex subunit 2
severity
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:12036940
RGD:14696682
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:166,664,251...166,703,814
G
ANXA1
annexin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
ANXA5
annexin A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 8:102,387,833...102,420,868
Ensembl chr 8:102,388,103...102,425,750
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 2:116,913,354...116,985,303
Ensembl chr 2:116,812,582...117,034,887
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:78,451,845...78,454,938
Ensembl chr 7:78,451,851...78,454,938
G
APOA1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
APOBEC3B
apolipoprotein B mRNA editing enzyme catalytic subunit 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23852168
NCBI chr 5:9,098,676...9,115,965
Ensembl chr 5:9,097,719...9,116,369
G
APOC3
apolipoprotein C3
ISO
protein:altered glycosylation::
RGD
PMID:19322776
RGD:153344619
NCBI chr 9:44,211,171...44,213,538
Ensembl chr 9:44,211,194...44,213,533
G
AQP4
aquaporin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:111,407,632...111,422,169
Ensembl chr 6:111,407,639...111,422,109
G
ARG1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
G
ARHGAP35
Rho GTPase activating protein 35
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 6:52,711,463...52,841,295
Ensembl chr 6:52,711,901...52,841,288
G
ARHGAP44
Rho GTPase activating protein 44
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:28527113
RGD:401901290
NCBI chr12:57,049,900...57,206,706
Ensembl chr12:57,049,895...57,206,889
G
ATP5PD
ATP synthase peripheral stalk subunit d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr12:6,241,467...6,247,344
G
ATRX
ATRX chromatin remodeler
disease_progression
ISO
RGD
PMID:31374064
RGD:127285382
NCBI chr X:61,584,028...61,872,341
Ensembl chr X:61,584,848...61,872,287
G
AXIN2
axin 2
susceptibility disease_progression
ISO
DNA:SNP:cds:p.P50S(human) DNA:SNPs::1712 +19 G>A,148 C>T(human)
RGD
PMID:16820935 PMID:30346805
RGD:151356655 RGD:151356657
NCBI chr12:12,311,293...12,343,207
Ensembl chr12:12,311,298...12,343,200
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
ISO
mRNA,protein:increased expression:lung
RGD
PMID:17724461
RGD:153350134
NCBI chr 3:7,867,521...7,874,857
G
B2M
beta-2-microglobulin
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:26619011
NCBI chr 1:126,865,767...126,878,501
Ensembl chr 1:126,864,468...126,871,554
G
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231345
NCBI chr13:34,544,570...34,553,538
Ensembl chr13:34,544,581...34,553,483
G
BHLHE41
basic helix-loop-helix family member e41
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:18223678
RGD:151665316
NCBI chr 5:47,687,662...47,692,761
Ensembl chr 5:47,686,404...47,692,762
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates
ISO
mRNA:increased expression:B cell (human)
RGD
PMID:33098370
RGD:153323293
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,002,734...33,020,242
G
BIRC5
baculoviral IAP repeat containing 5
ameliorates disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15001635 PMID:15035987 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15687339 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16439621 PMID:16474404 PMID:16772349 PMID:16825433 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17374713 PMID:17488796 PMID:17603483 PMID:17785355 PMID:18039235 PMID:18042262 PMID:18186519 PMID:18368129 PMID:18398503 PMID:18413255 PMID:18794803 PMID:19001320 PMID:19010912 PMID:19018267 PMID:19206169 PMID:19238210 PMID:19376813 PMID:19383316 PMID:19404918 PMID:19537845 PMID:19561230 PMID:19571295 PMID:19913317 PMID:20008640 PMID:20350999 PMID:20413299 PMID:20619739 PMID:20630094 PMID:20818844 PMID:20823850 PMID:20857202 PMID:21062266 PMID:21107320 PMID:21107323 PMID:21129611 PMID:21156289 PMID:21163703 PMID:21426297 PMID:21483012 PMID:21502544 PMID:21639808 PMID:21641636 PMID:21683865 PMID:21784453 PMID:21975775 PMID:22038996 PMID:22039425 PMID:22048237 PMID:22113612 PMID:22180495 PMID:22281684 PMID:22310681 PMID:22351686 PMID:22356324 PMID:22389471 PMID:22448344 PMID:22495831 PMID:22536370 PMID:22586120 PMID:22608338 PMID:22649091 PMID:22663011 PMID:22735384 PMID:22743296 PMID:22773810 PMID:22798288 PMID:22805292 PMID:22876591 PMID:22972589 PMID:22997239 PMID:23020132 PMID:23031422 PMID:23251002 PMID:23273605 PMID:23302800 PMID:23325582 PMID:23352452 PMID:23470635 PMID:23524406 PMID:23549875 PMID:23614898 PMID:23685455 PMID:23715574 PMID:23812671 PMID:23833300 PMID:23845441 PMID:23918947 PMID:24033266 PMID:24107445 PMID:24112392 PMID:24163374 PMID:24303953 PMID:24388723 PMID:24446311 PMID:24451042 PMID:24508103 PMID:24512911 PMID:24576830 PMID:24583796 PMID:24586605 PMID:24594804 PMID:24670642 PMID:24717435 PMID:24920063 PMID:25024077 PMID:25037139 PMID:25079330 PMID:25157968 PMID:25265492 PMID:25265494 PMID:25370471 PMID:25399551 PMID:25463315 PMID:25741868 PMID:25950823 PMID:25989278 PMID:26619011 PMID:26678033 PMID:27236105 PMID:27276561 PMID:27404270 PMID:27480103 PMID:28492532 PMID:28832562 PMID:28854169 PMID:28891408 PMID:29453417 PMID:29595366 PMID:29907801 PMID:29925953 PMID:31277584 PMID:31336229 PMID:31779674 PMID:31891627 PMID:34476331 More...
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
BTK
Bruton tyrosine kinase
exacerbates susceptibility
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:31803536 PMID:32351880
RGD:151347848 RGD:151347849
NCBI chr X:82,981,512...83,014,475
Ensembl chr X:82,981,515...83,014,573
G
BZW2
basic leucine zipper and W2 domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:85,887,801...85,947,414
Ensembl chr 9:85,886,158...85,947,410
G
CADM1
cell adhesion molecule 1
ISO
DNA, mRNA:hypermethylation, decreased expression:promoter:liver
RGD
PMID:16814249
RGD:2289096
NCBI chr 9:42,644,487...42,984,934
Ensembl chr 9:42,644,431...42,985,017
G
CALR
calreticulin
treatment
ISO
human cells and recombinant gene in a mouse model
RGD
PMID:18245558
RGD:150521698
NCBI chr 2:66,098,263...66,102,074
Ensembl chr 2:66,098,229...66,102,132
G
CAPG
capping actin protein, gelsolin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 3:59,335,483...59,366,855
Ensembl chr 3:59,339,966...59,366,846
G
CBX5
chromobox 5
disease_progression
ISO
mRNA,protein:increased expression:lung:
RGD
PMID:22900142
RGD:9586743
NCBI chr 5:19,446,083...19,484,527
Ensembl chr 5:19,446,086...19,484,463
G
CBX7
chromobox 7
ISO
mRNA,DNA:decreased expression, loss of heterozygosity:lung:
RGD
PMID:22214847
RGD:9587356
NCBI chr 5:9,070,312...9,090,467
Ensembl chr 5:9,070,353...9,087,634
G
CCND1
cyclin D1
disease_progression treatment
ISO
RGD
PMID:19355812 PMID:26681199
RGD:11536846 RGD:13434927
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCND2
cyclin D2
disease_progression
ISO
RGD
PMID:30308939
RGD:151665105
NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571
G
CCT5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr16:72,211,452...72,223,202
Ensembl chr16:72,208,012...72,223,114
G
CD163
CD163 molecule
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 5:63,300,200...63,334,497
Ensembl chr 5:63,300,231...63,334,498
G
CD44
CD44 molecule
disease_progression
ISO
mRNA:splice variants:lung mRNA:increased expression:lung (human)
RGD
PMID:18091389 PMID:29537891
RGD:149735539 RGD:2289345
NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
G
CDC73
cell division cycle 73
exacerbates
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:21692036
RGD:150537041
NCBI chr10:575,075...667,618
Ensembl chr10:575,075...667,432
G
CDH1
cadherin 1
ISO
DNA:increased methylation
RGD
PMID:16329148
RGD:1599556
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDK12
cyclin dependent kinase 12
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
NCBI chr12:22,755,365...22,831,397
Ensembl chr12:22,775,226...22,831,333
G
CDK4
cyclin dependent kinase 4
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:5377176 PMID:7652577 PMID:8528263 PMID:8968104 PMID:9228064 PMID:9425228 PMID:11756559 PMID:15880589 PMID:21801156 PMID:22804906 PMID:23384855 PMID:23546221 PMID:24256466 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:29774366 More...
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CDK6
cyclin dependent kinase 6
ISO
protein:increased expression:lung
RGD
PMID:10574260
RGD:13464325
NCBI chr 9:72,510,858...72,765,631
Ensembl chr 9:72,518,101...72,764,129
G
CHD4
chromodomain helicase DNA binding protein 4
ameliorates susceptibility
ISO
mRNA:increased expression:lung (human) human cells in a mouse model DNA:missense mutation:CDS:p.D140E (rs7479004) (human)
RGD
PMID:28486105 PMID:29667179 PMID:32228507
RGD:151660359 RGD:153323299 RGD:153323307
NCBI chr 5:64,071,627...64,105,212
Ensembl chr 5:64,065,992...64,105,173
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
susceptibility
ISO
associated with smoking; DNA:SNP: :rs1051730(human) ClinVar Annotator: match by term: Lung adenocarcinoma DNA:SNP: :rs8042374(human)
RGD ClinVar
PMID:20554942 PMID:24686516 PMID:27993330
RGD:150527848 RGD:151347530
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,899...47,384,303
G
CHRNA5
cholinergic receptor nicotinic alpha 5 subunit
susceptibility disease_progression
ISO
DNA:SNP: :rs503464(human) ClinVar Annotator: match by term: Lung adenocarcinoma associated with smoking; DNA:SNPs: :rs2036527, rs684513, rs667282(human) DNA:SNP:cds: p.D398N(human)
RGD ClinVar
PMID:19577767 PMID:20554942 PMID:23314339 PMID:27993330
RGD:150524359 RGD:150527848 RGD:150527849
NCBI chr 7:47,382,860...47,425,871
Ensembl chr 7:47,383,792...47,425,841
G
CHRNB4
cholinergic receptor nicotinic beta 4 subunit
ISO
mRNA:increased expression:lung DNA:hypomethylation:promoter:
RGD
PMID:20124469 PMID:22945651
RGD:150527851 RGD:151361154
NCBI chr 7:47,338,819...47,359,064
G
CLPTM1L
CLPTM1 like
susceptibility no_association ameliorates
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP::rs77518573(human) DNA:SNP: :rs401681(human) DNA:SNP::rs401681(human) DNA:SNP:: rs31490(human) mRNA:increased expression:lung DNA:SNP:: rs4975616(human)
CTD RGD
PMID:19955392 PMID:22675468 PMID:23738012 PMID:23908149 PMID:24366883 PMID:24386361 PMID:24861918 PMID:31935503 More...
RGD:150530483 RGD:150530485 RGD:150530498 RGD:150530499 RGD:150530502 RGD:150530635 RGD:150537098
NCBI chr16:79,237,000...79,248,503
Ensembl chr16:79,237,061...79,248,500
G
CMTR2
cap methyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 6:14,325,869...14,334,043
Ensembl chr 6:14,323,981...14,334,008
G
COL10A1
collagen type X alpha 1 chain
disease_progression
ISO
mRNA:increased expression:lung
RGD
PMID:33324550
RGD:150429752
NCBI chr 1:81,766,829...81,773,818
Ensembl chr 1:81,765,859...81,773,818
G
CREBBP
CREB binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 3:38,388,366...38,530,243
Ensembl chr 3:38,388,547...38,530,224
G
CSF1R
colony stimulating factor 1 receptor
ISO
protein:increased expression:lung (human)
RGD
PMID:23702648
RGD:150524280
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSRP3
cysteine and glycine rich protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:40,219,288...40,240,614
Ensembl chr 2:40,215,353...40,240,616
G
CTNNB1
catenin beta 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma ClinVar Annotator: match by term: Adenocarcinoma of lung
ClinVar
PMID:10192393 PMID:25741868 PMID:26619011
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
CXCR4
C-X-C motif chemokine receptor 4
exacerbates
ISO
protein:increased expression:lung (human) mRNA:increased expression:lung (human)
RGD
PMID:19716197 PMID:30103827
RGD:152023735 RGD:152177480
NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
ISO
protein:increased expression:lung (human)
RGD
PMID:19358281
RGD:152177688
NCBI chr 3:102,195,743...102,205,687
Ensembl chr 3:102,195,741...102,205,683
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
ameliorates
ISO
DNA:hypomethylation:promoter (human) mRNA:decreased expression:lung (human) human cell line in a mouse model
RGD
PMID:24736069 PMID:25519225 PMID:27793774
RGD:151361181 RGD:151665173 RGD:151665499
NCBI chr17:55,110,546...55,130,328
Ensembl chr17:55,110,590...55,130,363
G
CYP2A19
cytochrome P450 family 2 subfamily A member 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18669584
NCBI chr 6:49,056,579...49,064,111
Ensembl chr 6:49,056,578...49,064,107
G
DDR2
discoidin domain receptor tyrosine kinase 2
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296
G
DLL4
delta like canonical Notch ligand 4
treatment
ISO
RGD
PMID:33628824
RGD:155663482
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
DNMT3A
DNA methyltransferase 3 alpha
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:21067377 PMID:21518476 PMID:22160010 PMID:22722925 PMID:22744846 PMID:22898539 PMID:22898541 PMID:24606448 PMID:24622842 PMID:24656771 PMID:25741868 PMID:26619011 PMID:26822784 PMID:26876596 PMID:27317772 PMID:27991732 PMID:28166811 PMID:28252636 PMID:28432085 PMID:28492532 PMID:28941052 PMID:29900417 PMID:30185810 PMID:30478443 PMID:31582562 PMID:31620784 PMID:31640986 PMID:31961069 PMID:32123902 PMID:32385248 PMID:34788385 More...
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
G
DNMT3B
DNA methyltransferase 3 beta
susceptibility
ISO
DNA:SNPs,haplotype:promoter:-283T >C,-579G>T(human)
RGD
PMID:15528220
RGD:9589086
NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
G
DOK1
docking protein 1
disease_progression
ISO
RGD
PMID:20139980
RGD:152177521
NCBI chr 3:68,494,516...68,497,374
Ensembl chr 3:68,494,520...68,497,407
G
DOK2
docking protein 2
exacerbates disease_progression
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:20139980 PMID:24255704 PMID:30475228
RGD:152177492 RGD:152177493 RGD:152177521
NCBI chr14:6,176,487...6,180,895
Ensembl chr14:6,177,009...6,188,708
G
DOK3
docking protein 3
disease_progression
ISO
RGD
PMID:20139980
RGD:152177521
NCBI chr 2:80,440,774...80,445,484
Ensembl chr 2:80,439,247...80,445,482
G
DOT1L
DOT1 like histone lysine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 2:76,339,452...76,401,974
Ensembl chr 2:76,339,470...76,401,965
G
E2F1
E2F transcription factor 1
ISO
mRNA:increased expression:lung
RGD
PMID:26695082
RGD:13464334
NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883
G
E2F3
E2F transcription factor 3
ISO
RGD
PMID:16938365
RGD:13464341
NCBI chr 7:15,793,519...15,870,213
Ensembl chr 7:15,794,178...15,870,204
G
EEF2
eukaryotic translation elongation factor 2
exacerbates
ISO
protein:increased expression:lung (human)
RGD
PMID:21554491
RGD:153298904
NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680
G
EEF2K
eukaryotic elongation factor 2 kinase
ameliorates
ISO
Human cells in mouse model
RGD
PMID:30522114
RGD:153298964
NCBI chr 3:23,887,120...23,980,231
Ensembl chr 3:23,887,125...23,956,373
G
EGF
epidermal growth factor
ISO
DNA:polymorphism: :p.A61G (human)
RGD
PMID:26625757
RGD:11538684
NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046
G
EGFR
epidermal growth factor receptor
disease_progression
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic | ClinVar Annotator: match by term: Lung adenocarcinoma
RGD ClinVar
PMID:11423618 PMID:15118073 PMID:15118125 PMID:15272417 PMID:15329413 PMID:15604253 PMID:15623594 PMID:15625347 PMID:15625379 PMID:15728811 PMID:15737014 PMID:15741570 PMID:15788655 PMID:15897572 PMID:15901872 PMID:15998907 PMID:16105816 PMID:16115929 PMID:16187797 PMID:16199108 PMID:16203769 PMID:16204011 PMID:16258541 PMID:16467085 PMID:16533793 PMID:16863509 PMID:16865253 PMID:16912157 PMID:16956694 PMID:17020982 PMID:17047654 PMID:17085664 PMID:17106442 PMID:17177598 PMID:17192902 PMID:17236554 PMID:17285735 PMID:17317677 PMID:17387341 PMID:17429313 PMID:17473653 PMID:17473659 PMID:17510392 PMID:17726540 PMID:17904685 PMID:17941001 PMID:18093943 PMID:18176089 PMID:18227510 PMID:18261621 PMID:18325048 PMID:18334834 PMID:18596266 PMID:18948947 PMID:18981003 PMID:18992959 PMID:19096301 PMID:19096324 PMID:19147750 PMID:19381876 PMID:19536777 PMID:19589612 PMID:19692680 PMID:20022809 PMID:20033049 PMID:20038723 PMID:20068085 PMID:20129249 PMID:20479403 PMID:20559149 PMID:20573926 PMID:20808254 PMID:20942962 PMID:21057810 PMID:21233402 PMID:21248300 PMID:21252721 PMID:21317742 PMID:21430269 PMID:21527506 PMID:21592614 PMID:21841502 PMID:21899495 PMID:21900837 PMID:21921847 PMID:22019513 PMID:22215752 PMID:22370314 PMID:22483783 PMID:22588155 PMID:22760226 PMID:22809298 PMID:22992668 PMID:23371856 PMID:23468066 PMID:23540867 PMID:24033266 PMID:24039832 PMID:24202392 PMID:24212795 PMID:24453288 PMID:24478319 PMID:24736066 PMID:24736080 PMID:25061320 PMID:25382819 PMID:25741868 PMID:26066407 PMID:26490356 PMID:26700910 PMID:26824984 PMID:27294619 PMID:27993330 PMID:28492532 PMID:28947568 PMID:29100434 PMID:29228562 PMID:30098700 PMID:30610926 PMID:31721094 PMID:32171629 PMID:32978515 PMID:32978518 PMID:33858029 PMID:1111234672 More...
RGD:126790475
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EHMT2
euchromatic histone lysine methyltransferase 2
disease_progression
ISO
RGD
PMID:20940408
RGD:9589170
NCBI chr 7:23,977,683...23,992,673
Ensembl chr 7:23,977,683...23,992,697
G
EIF2B1
eukaryotic translation initiation factor 2B subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:29,355,497...29,367,918
Ensembl chr14:29,332,233...29,367,918
G
EIF2B4
eukaryotic translation initiation factor 2B subunit delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24366584
NCBI chr 3:111,781,661...111,786,377
Ensembl chr 3:111,781,648...111,786,372
G
EIF2B5
eukaryotic translation initiation factor 2B subunit epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24366584
NCBI chr13:122,060,408...122,070,327
Ensembl chr13:122,060,473...122,070,304
G
EIF3E
eukaryotic translation initiation factor 3 subunit E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:29,288,878...29,343,593
Ensembl chr 4:29,264,042...29,352,902
G
EML4
EMAP like 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22980554 PMID:22999080
NCBI chr 3:98,005,809...98,155,876
Ensembl chr 3:98,005,812...98,155,846
G
EMX2
empty spiracles homeobox 2
exacerbates
ISO
mRNA,protein:decreased expression:lung (human)
RGD
PMID:21726823
RGD:153323303
NCBI chr14:127,649,675...127,656,972
Ensembl chr14:127,650,688...127,655,706
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893 PMID:27602772
NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
G
EP300
E1A binding protein p300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 5:7,311,165...7,394,515
Ensembl chr 5:7,311,171...7,393,760
G
ERBB2
erb-b2 receptor tyrosine kinase 2
disease_progression
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
RGD ClinVar
PMID:15457249 PMID:15753357 PMID:16638863 PMID:18334834 PMID:22325357 PMID:22761469 PMID:24033266 PMID:26824984 More...
RGD:126790475
NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
G
ERBB3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:26824984
RGD:126790475
NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038
G
ERBB4
erb-b2 receptor tyrosine kinase 4
disease_progression
ISO
RGD
PMID:26824984
RGD:126790475
NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21327329
NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984
G
ERCC6
ERCC excision repair 6, chromatin remodeling factor
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:31615563
RGD:155260344
NCBI chr14:89,998,125...90,075,911
Ensembl chr14:90,002,024...90,075,898
G
ERCC6L
ERCC excision repair 6 like, spindle assembly checkpoint helicase
exacerbates
ISO
mRNA:increased expression:lung (human)
RGD
PMID:35150321
RGD:155260359
NCBI chr X:58,087,216...58,117,942
Ensembl chr X:58,087,169...58,117,947
G
ERGIC3
ERGIC and golgi 3
disease_progression ameliorates
ISO
mRNA,protein:increased expression:lung (human)
RGD
PMID:23374247 PMID:27588471
RGD:151708716 RGD:153323314
NCBI chr17:38,884,830...38,899,140
Ensembl chr17:38,885,117...38,899,138
G
ERP29
endoplasmic reticulum protein 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr14:39,687,028...39,695,748
Ensembl chr14:39,687,000...39,695,752
G
ESCO2
establishment of sister chromatid cohesion N-acetyltransferase 2
ameliorates
ISO
RGD
PMID:33573689
RGD:155791670
NCBI chr14:11,495,297...11,532,898
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
disease_progression
ISO
RGD
PMID:24097870
RGD:126781716
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
FAS
Fas cell surface death receptor
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:29254206
RGD:151665107
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASN
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
G
FBL
fibrillarin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:48,314,782...48,326,433
Ensembl chr 6:48,314,783...48,326,436
G
FES
FES proto-oncogene, tyrosine kinase
treatment
ISO
human cells in a mouse model
RGD
PMID:31573955
RGD:153323295
NCBI chr 7:53,472,947...53,485,084
Ensembl chr 7:53,472,947...53,485,082
G
FGF10
fibroblast growth factor 10
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr16:28,695,465...28,779,953
Ensembl chr16:28,695,470...28,777,509
G
FGF18
fibroblast growth factor 18
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:19296538
RGD:150429981
NCBI chr16:52,724,867...52,760,246
Ensembl chr16:52,725,356...52,759,791
G
FGF9
fibroblast growth factor 9
disease_progression
ISO
protein:increased expression:lung (human) mRNA:decreased expression:lung (human)
RGD
PMID:19296538 PMID:19358281 PMID:20464547
RGD:150429981 RGD:152177688 RGD:152975620
NCBI chr11:1,554,648...1,581,938
Ensembl chr11:1,554,763...1,582,408
G
FGFR4
fibroblast growth factor receptor 4
disease_progression exacerbates
ISO
human cells in mouse model DNA:SNP:exon 9: p.G388R (rs351855)(human) DNA:SNP:exon 9: p.G388R (human)
RGD
PMID:16061909 PMID:19296538 PMID:29402970
RGD:150429976 RGD:150429981 RGD:150429984
NCBI chr 2:80,841,536...80,853,791
Ensembl chr 2:80,841,536...80,853,796
G
FKBP11
FKBP prolyl isomerase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:14,959,305...14,964,231
Ensembl chr 5:14,961,518...14,963,546
G
FLT1
fms related receptor tyrosine kinase 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
G
FOXA1
forkhead box A1
ISO
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12234996 PMID:29072684 PMID:34254728
RGD:151665758 RGD:151665822
NCBI chr 7:62,471,233...62,479,638
Ensembl chr 7:62,471,249...62,479,220
G
FOXO3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19380174
NCBI chr 1:74,626,673...74,760,323
Ensembl chr 1:74,628,218...74,760,325
G
FOXP1
forkhead box P1
ISO
mRNA:decreased expression:lung (rat)
RGD
PMID:16023287
RGD:11561933
NCBI chr13:52,346,844...52,974,358
Ensembl chr13:52,348,234...52,876,892
G
FOXP2
forkhead box P2
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr18:31,335,102...31,890,523
Ensembl chr18:31,335,264...31,888,845
G
FOXP4
forkhead box P4
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 7:36,760,643...36,793,620
Ensembl chr 7:36,742,752...36,793,619
G
FRZB
frizzled related protein
severity
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:27623992
RGD:32716395
NCBI chr15:88,332,856...88,377,275
Ensembl chr15:88,332,860...88,377,247
G
FUBP1
far upstream element binding protein 1
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:32481602
RGD:151361197
NCBI chr 6:135,281,474...135,319,055
Ensembl chr 6:135,281,521...135,318,714
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
G
GAR1
GAR1 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:112,401,114...112,414,277
Ensembl chr 8:112,400,005...112,414,033
G
GART
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:197,130,898...197,158,797
Ensembl chr13:197,130,904...197,161,891
G
GJB2
gap junction protein beta 2
ISO
DNA, mRNA:hypermethylation, decreased expression:lung
RGD
PMID:16637067
RGD:11568669
NCBI chr11:774,090...781,252
Ensembl chr11:775,166...775,846
G
GNG11
G protein subunit gamma 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24366584
NCBI chr 9:73,721,327...73,726,229
Ensembl chr 9:73,721,322...73,726,222
G
GNPNAT1
glucosamine-phosphate N-acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:182,404,460...182,423,453
Ensembl chr 1:182,407,229...182,423,441
G
GOLM1
golgi membrane protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:29,117,578...29,219,024
Ensembl chr10:29,118,314...29,219,018
G
GPI
glucose-6-phosphate isomerase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:44,038,374...44,069,331
Ensembl chr 6:44,038,357...44,069,328
G
GPX3
glutathione peroxidase 3
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:23374247
RGD:151708716
NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026
G
GRWD1
glutamate rich WD repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:53,849,673...53,856,229
Ensembl chr 6:53,849,852...53,859,385
G
H1-10
H1.10 linker histone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:71,760,464...71,762,035
Ensembl chr13:71,760,467...71,761,839
G
HELLS
helicase, lymphoid specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:105,923,727...105,967,003
Ensembl chr14:105,924,536...105,955,430
G
HK1
hexokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:72,383,328...72,460,927
Ensembl chr14:72,351,246...72,460,924
G
HK2
hexokinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:68,155,656...68,231,187
Ensembl chr 3:68,153,835...68,231,615
G
HMGB2
high mobility group box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24366584 PMID:27602772
NCBI chr14:16,709,966...16,712,288
Ensembl chr14:16,710,047...16,717,101
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
HOXB7
homeobox B7
severity
ISO
protein:increased expression:lung epithelium (human)
RGD
PMID:22911672
RGD:10402176
NCBI chr12:24,861,165...24,864,675
Ensembl chr12:24,861,174...24,864,620
G
HRAS
HRas proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28328122 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
HSD17B10
hydroxysteroid 17-beta dehydrogenase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr X:46,218,540...46,220,942
Ensembl chr X:46,218,548...46,220,883
G
HSP90B1
heat shock protein 90 beta family member 1
ISO
mRNA:increased expression:lung (human)
RGD
PMID:23374247
RGD:151708716
NCBI chr 5:80,511,513...80,531,016
Ensembl chr 5:80,511,506...80,530,991
G
HSPB1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 3:10,038,074...10,039,441
Ensembl chr 3:10,037,949...10,039,704
G
HTR4
5-hydroxytryptamine receptor 4
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 2:149,768,295...149,813,801
Ensembl chr 2:149,731,034...149,912,495
G
HTRA1
HtrA serine peptidase 1
disease_progression
ISO
human cells in mouse model
RGD
PMID:24356998
RGD:152975621
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
disease_progression
ISO
mRNA:increased expression:lung (human) ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma protein:increased expression:blood plasma (human)
RGD ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24046070 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:29537891 PMID:30231226 PMID:36201590 More...
RGD:149735539 RGD:149735540
NCBI chr15:111,341,153...111,362,330
Ensembl chr15:111,341,153...111,362,296
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
protein:increased expression:lung (human) protein:increased expression:blood serum (human)
RGD
PMID:29465809 PMID:30128035
RGD:149735564 RGD:149735567
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
IGF2R
insulin like growth factor 2 receptor
ISO
mRNA:deletions: :c.3698_4902del, c.3366_4902del, c.3817_4697del (rat)
RGD
PMID:12503077
RGD:1298968
NCBI chr 1:7,369,485...7,472,480
Ensembl chr 1:7,368,103...7,472,548
G
IKZF1
IKAROS family zinc finger 1
exacerbates ameliorates
ISO
protein:increased expression:lung (human) mRNA:increased expression:lung (human)
RGD
PMID:32787735 PMID:33738286
RGD:150540324 RGD:151347632
NCBI chr 9:136,372,202...136,464,942
Ensembl chr 9:136,372,725...136,464,940
G
IL1R2
interleukin 1 receptor type 2
disease_progression severity
ISO
mRNA:altered expression:lung (human) mRNA:increased expression:lung (human)
RGD
PMID:29942094 PMID:31921619
RGD:152998982 RGD:152998998
NCBI chr 3:52,367,434...52,406,393
Ensembl chr 3:52,367,437...52,406,334
G
IMPDH2
inosine monophosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:31,658,642...31,663,660
Ensembl chr13:31,658,650...31,663,552
G
IPO4
importin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:75,109,844...75,118,739
Ensembl chr 7:75,110,082...75,118,733
G
IPO5
importin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:67,019,299...67,059,375
Ensembl chr11:67,004,109...67,060,551
G
IQSEC1
IQ motif and Sec7 domain ArfGEF 1
disease_progression
ISO
RGD
PMID:24902879
RGD:153350085
NCBI chr13:71,203,967...71,366,685
Ensembl chr13:71,031,001...71,366,684
G
IRAK3
interleukin 1 receptor associated kinase 3
ISO
mRNA:increased expression:lung (human)
RGD
PMID:21278795
RGD:36049796
NCBI chr 5:30,524,704...30,601,067
Ensembl chr 5:30,526,793...30,609,921
G
IREB2
iron responsive element binding protein 2
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 7:47,481,539...47,529,199
Ensembl chr 7:47,478,706...47,529,242
G
JAK2
Janus kinase 2
treatment
ISO
human cells in mouse model
RGD
PMID:27025877
RGD:11574134
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24366584
NCBI chr 2:66,214,086...66,219,435
Ensembl chr 2:66,214,138...66,217,002
G
KCNJ4
potassium inwardly rectifying channel subfamily J member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30512237
NCBI chr 5:9,526,399...9,549,290
Ensembl chr 5:9,547,177...9,548,520
G
KLF5
KLF transcription factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr11:45,370,009...45,386,673
Ensembl chr11:45,369,810...45,388,314
G
KMT2C
lysine methyltransferase 2C
disease_progression onset
ISO
RGD
PMID:30821106 PMID:32867667
RGD:151356760 RGD:151356761
NCBI chr18:4,993,213...5,279,668
Ensembl chr18:4,993,227...5,278,723
G
KPNA2
karyopherin subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:14,283,092...14,296,749
Ensembl chr12:14,283,087...14,296,746
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:2278970 PMID:3122217 PMID:6320174 PMID:11745231 PMID:12460918 PMID:15696205 PMID:16051643 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17384584 PMID:17704260 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:19794967 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21975775 PMID:22282465 PMID:22407852 PMID:22722830 PMID:23014527 PMID:23182985 PMID:23325582 PMID:23406027 PMID:25044103 PMID:25157968 PMID:26242988 PMID:26619011 PMID:28492532 PMID:31666701 PMID:35658005 More...
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LDHA
lactate dehydrogenase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
G
LECT2
leukocyte cell derived chemotaxin 2
ameliorates
ISO
human cells in mouse model
RGD
PMID:30453282
RGD:153323337
NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464
G
LMNA
lamin A/C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 4:93,899,019...93,927,255
Ensembl chr 4:93,899,019...93,926,320
G
LMNB1
lamin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:129,807,228...129,862,211
Ensembl chr 2:129,807,318...129,872,270
G
LRP1B
LDL receptor related protein 1B
disease_progression
ISO
DNA:mutations:multiple: (human)
RGD
PMID:18948947
RGD:11064706
NCBI chr15:9,612,805...11,499,969
Ensembl chr15:9,613,238...11,499,530
G
LRRC56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28328122 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
NCBI chr 2:303,836...323,701
Ensembl chr 2:304,430...323,699
G
MAP2K1
mitogen-activated protein kinase kinase 1
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung mRNA:increased expression:lung (human) CTD Direct Evidence: marker/mechanism
ClinVar RGD CTD
PMID:22135231 PMID:26619011 PMID:29254206
RGD:151665107
NCBI chr 1:164,381,892...164,469,313
Ensembl chr 1:164,381,845...164,471,226
G
MAP2K4
mitogen-activated protein kinase kinase 4
severity
ISO
RGD
PMID:12231543 PMID:21896780
RGD:150429783 RGD:150429821
NCBI chr12:56,402,029...56,516,217
Ensembl chr12:56,402,075...56,516,238
G
MAP2K7
mitogen-activated protein kinase kinase 7
exacerbates
ISO
human gene in a mouse model
RGD
PMID:34236045
RGD:155230828
NCBI chr 2:71,299,010...71,308,432
Ensembl chr 2:71,298,325...71,308,124
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:23533274
RGD:151356978
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
G
MAP4K4
mitogen-activated protein kinase kinase kinase kinase 4
exacerbates ameliorates
ISO
protein:increased expression:lung (human) mRNA, protein:increased expression:lung (human) human cell line in a mouse model
RGD
PMID:22824148 PMID:28306189 PMID:33510968
RGD:151347677 RGD:151347678 RGD:151347681
NCBI chr 3:52,483,028...52,649,480
Ensembl chr 3:52,484,274...52,649,410
G
MAPK14
mitogen-activated protein kinase 14
exacerbates
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31969449
RGD:151665505
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
severity treatment
ISO
mRNA:increased expression:lung (human) human cells in mouse model
RGD
PMID:31200834
RGD:151356911
NCBI chr 4:98,562,092...98,567,014
Ensembl chr 4:98,534,812...98,567,006
G
MEOX1
mesenchyme homeobox 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34837450
NCBI chr12:19,431,397...19,452,430
Ensembl chr12:19,431,420...19,451,993
G
MIER3
MIER family member 3
ameliorates
ISO
RGD
PMID:35117188
RGD:407571696
NCBI chr16:35,990,468...36,025,424
Ensembl chr16:35,990,469...36,025,436
G
MIR127
microRNA mir-127
treatment
ISO
Human cells in mouse model
RGD
PMID:27869168
RGD:152995353
NCBI chr 7:121,709,636...121,709,715
Ensembl chr 7:121,709,640...121,709,720
G
MIR20A
microRNA mir-20a
ISO
RGD
PMID:26560875
RGD:11572141
NCBI chr11:60,735,109...60,735,179
Ensembl chr11:60,735,099...60,735,196
G
MIR21
microRNA mir-21
disease_progression
ISO
RNA:increased expression:lung (human) miRNA:increased expression:sputum (human)
RGD
PMID:27777637 PMID:29892003
RGD:152998892 RGD:152998954
NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
G
MIR31
microRNA mir-31
severity disease_progression
ISO
RNA:increased expression:lung (human)
RGD
PMID:23946296 PMID:26657862 PMID:27215092 PMID:29367106
RGD:11250998 RGD:11343268 RGD:152998944 RGD:152998945
NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809
G
MIR432
microRNA mir-432
disease_progression
ISO
mRNA:decreased expression:lung (human) human cells in mouse model
RGD
PMID:26942465
RGD:152999419
NCBI chr 7:121,711,137...121,711,216
Ensembl chr 7:121,711,137...121,711,216
G
MKI67
marker of proliferation Ki-67
disease_progression
ISO
protein:altered expression:lung (human)
RGD
PMID:26942465
RGD:152999419
NCBI chr14:137,266,622...137,296,312
G
MLH1
mutL homolog 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr13:21,791,276...21,877,789
Ensembl chr13:21,791,203...21,877,757
G
MRE11
MRE11 homolog, double strand break repair nuclease
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:26,572,352...26,634,596
Ensembl chr 9:26,572,361...26,634,567
G
MRPL12
mitochondrial ribosomal protein L12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:1,200,458...1,203,817
Ensembl chr12:1,200,461...1,203,822
G
MRPS5
mitochondrial ribosomal protein S5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:46,137,566...46,169,403
Ensembl chr 3:46,137,509...46,169,807
G
MS4A1
membrane spanning 4-domains A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22514692
NCBI chr 2:11,216,238...11,229,060
Ensembl chr 2:11,215,901...11,222,914
G
MSH2
mutS homolog 2
no_association
ISO
DNA:polymorphisms:introns:IVS10+12A>G, IVS12-6T>C (human) DNA:polymorphisms:promoter, intron:-118T>C, IVS1+9G>C (human)
RGD
PMID:16614121
RGD:11065547
NCBI chr 3:93,082,958...93,163,556
Ensembl chr 3:93,081,219...93,163,585
G
MSH3
mutS homolog 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21327329
NCBI chr 2:89,255,647...89,456,102
Ensembl chr 2:89,250,003...89,453,936
G
MSH6
mutS homolog 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21327329
NCBI chr 3:92,792,590...92,814,154
Ensembl chr 3:92,785,664...92,814,238
G
MUC1
mucin 1, cell surface associated
ISO
mRNA:increased expression:lung
RGD
PMID:8694545
RGD:5131260
NCBI chr 4:94,626,317...94,631,194
G
MUC4
mucin 4, cell surface associated
disease_progression
ISO
protein:increased expression:trachea
RGD
PMID:17126950
RGD:5131208
NCBI chr13:134,192,412...134,248,435
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 2:757,897...790,321
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism human cell line in mouse model
CTD RGD
PMID:20033209 PMID:26656844 PMID:27602772
RGD:7207787
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
MYD88
MYD88 innate immune signal transduction adaptor
treatment ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:30712876 PMID:32140881
RGD:150520172 RGD:150540309
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
NAA10
N-alpha-acetyltransferase 10, NatA catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:124,658,429...124,662,744
Ensembl chr X:124,658,158...124,662,702
G
NAIP
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr16:47,700,869...47,710,036
G
NCAPG
non-SMC condensin I complex subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34419073
NCBI chr 8:12,759,225...12,807,164
Ensembl chr 8:12,759,641...12,807,163
G
NCL
nucleolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:132,163,453...132,174,214
Ensembl chr15:132,162,516...132,174,172
G
NKX2-1
NK2 homeobox 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 7:63,487,200...63,491,580
Ensembl chr 7:63,487,807...63,491,575
G
NLRP3
NLR family pyrin domain containing 3
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 2:56,892,241...56,977,412
Ensembl chr 2:56,892,243...56,977,228
G
NOP56
NOP56 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr17:32,960,099...32,965,396
Ensembl chr17:32,960,102...32,965,370
G
NOP58
NOP58 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:105,893,589...105,930,458
Ensembl chr15:105,893,637...105,930,459
G
NOTCH1
notch receptor 1
treatment
ISO
RGD
PMID:33628824
RGD:155663482
G
NPM1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr16:52,767,263...52,781,862
Ensembl chr16:52,765,298...52,781,771
G
NPM3
nucleophosmin/nucleoplasmin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:112,819,390...112,822,244
Ensembl chr14:112,819,393...112,821,367
G
NUDT21
nudix hydrolase 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:29,339,893...29,359,596
Ensembl chr 6:29,339,841...29,363,312
G
NUF2
NUF2 component of NDC80 kinetochore complex
disease_progression
ISO
RGD
PMID:32226507
RGD:28912743
NCBI chr 4:87,162,873...87,194,193
Ensembl chr 4:87,162,818...87,194,170
G
OGG1
8-oxoguanine DNA glycosylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23951099
NCBI chr13:66,038,669...66,045,478
G
PABPC4
poly(A) binding protein cytoplasmic 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:95,382,295...95,399,452
Ensembl chr 6:95,382,302...95,399,080
G
PACRG
parkin coregulated
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:12719539
NCBI chr 1:4,964,686...5,465,258
Ensembl chr 1:4,967,224...5,465,064
G
PCBD1
pterin-4 alpha-carbinolamine dehydratase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:73,769,339...73,807,278
Ensembl chr14:73,800,765...73,807,281
G
PIGN
phosphatidylinositol glycan anchor biosynthesis class N
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:159,317,734...159,417,335
Ensembl chr 1:159,317,734...159,417,327
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18074223 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20581867 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24497998 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25741868 PMID:25880439 PMID:25915946 PMID:26266975 PMID:26266985 PMID:26351730 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:28941273 PMID:29446767 PMID:29549527 PMID:29661094 PMID:29758562 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 PMID:37712948 More...
NCBI chr13:117,193,935...117,282,151
Ensembl chr13:117,180,544...117,274,587
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
ISO
mRNA:decreased expression:lung
RGD
PMID:26695082
RGD:13464334
NCBI chr16:46,434,757...46,523,626
Ensembl chr16:46,511,521...46,523,609
G
PITX2
paired like homeodomain 2
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 8:111,697,364...111,723,295
Ensembl chr 8:111,698,757...111,723,298
G
PLCG1
phospholipase C gamma 1
exacerbates
ISO
protein:decreased expression:lung (human)
RGD
PMID:33077911
RGD:151356960
NCBI chr17:43,810,003...43,844,553
Ensembl chr17:43,810,048...43,844,554
G
PLOD2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
disease_progression
ISO
RGD
PMID:29072684
RGD:151665822
NCBI chr13:86,402,673...86,513,167
Ensembl chr13:86,401,244...86,513,105
G
POLD1
DNA polymerase delta 1, catalytic subunit
exacerbates
ISO
protein:increased expression:lung (human)
RGD
PMID:33442399
RGD:153323317
NCBI chr 6:55,247,799...55,272,087
Ensembl chr 6:55,247,880...55,272,085
G
POLR1D
RNA polymerase I and III subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:5,044,274...5,045,921
Ensembl chr11:5,044,329...5,089,766
G
PPAN
peter pan homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:68,958,906...68,962,657
Ensembl chr 2:68,958,906...68,962,657
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 8:119,429,181...119,754,615
Ensembl chr 8:119,428,779...119,753,105
G
PRAME
PRAME nuclear receptor transcriptional regulator
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:27241212
RGD:11535020
NCBI chr14:48,901,097...48,906,855
Ensembl chr14:48,899,343...48,911,231
G
PRDM1
PR/SET domain 1
exacerbates
ISO
RGD
PMID:28378641
RGD:150530469
NCBI chr 1:72,309,096...72,335,474
Ensembl chr 1:72,311,880...72,335,466
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:10072423 PMID:12719539 PMID:20301651 PMID:22956510 PMID:25741868 PMID:28492532 PMID:32647592 More...
NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872
G
PSAT1
phosphoserine aminotransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:231,142,673...231,172,364
Ensembl chr 1:231,142,625...231,172,360
G
PTCH1
patched 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330 PMID:28492532
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
G
PTEN
phosphatase and tensin homolog
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr14:99,929,590...100,021,619
G
PTPN13
protein tyrosine phosphatase non-receptor type 13
exacerbates susceptibility
ISO
mRNA,protein:decreased expression:lung DNA:missense mutations:cds:p.I1522M, p.Y2081D (human)
RGD
PMID:19672627 PMID:22245727 PMID:33536603
RGD:152176663 RGD:152176665 RGD:152975626
NCBI chr 8:132,035,170...132,200,425
Ensembl chr 8:132,035,151...132,249,411
G
PTPRB
protein tyrosine phosphatase receptor type B
disease_progression
ISO
mRNA:decreased expression:lung (human) mRNA:altered expression:lung (human)
RGD
PMID:7981622 PMID:29254206
RGD:151665107 RGD:151665112
NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289
G
PTPRJ
protein tyrosine phosphatase receptor type J
susceptibility
ISO
DNA:missense mutations:cds:p.R326Q, p.Q276P (human)
RGD
PMID:19672627
RGD:152176665
NCBI chr 2:14,548,489...14,724,823
Ensembl chr 2:14,548,428...14,724,474
G
RAC1
Rac family small GTPase 1
exacerbates ameliorates
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31779616 PMID:32366477
RGD:152998910 RGD:153345550
NCBI chr 3:4,781,776...4,803,510
Ensembl chr 3:4,781,780...4,803,543
G
RAF1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:1760348 PMID:8601312 PMID:10064593 PMID:12077328 PMID:17603482 PMID:17603483 PMID:19568997 PMID:19953625 PMID:20052757 PMID:20301557 PMID:21440552 PMID:21784453 PMID:22389993 PMID:23312806 PMID:23321623 PMID:23877478 PMID:24033266 PMID:24775816 PMID:25706034 PMID:25741868 PMID:26619011 PMID:26918529 PMID:27631234 PMID:28492532 PMID:28973083 PMID:28991257 PMID:29084544 PMID:29493581 PMID:30105547 PMID:30138938 PMID:30384889 PMID:31560489 PMID:32573669 PMID:33240318 More...
NCBI chr13:68,581,128...68,657,911
Ensembl chr13:68,580,812...68,657,829
G
RANGRF
RAN guanine nucleotide release factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:53,484,584...53,486,716
Ensembl chr12:53,485,265...53,486,713
G
RARB
retinoic acid receptor beta
ISO
DNA:hypomethylation:lung
RGD
PMID:26695082
RGD:13464334
NCBI chr13:12,336,387...12,507,688
Ensembl chr13:12,336,972...12,507,680
G
RASA1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 2:94,879,615...94,992,725
Ensembl chr 2:94,878,911...94,993,450
G
RB1
RB transcriptional corepressor 1
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
G
RBM10
RNA binding motif protein 10
ISO
DNA:missense mutations, protein-truncating variants: :multiple mRNA, protein:decreased expression:lung
RGD
PMID:22980975 PMID:29085465 PMID:30955253
RGD:11097386 RGD:151356983 RGD:151356984
NCBI chr X:41,773,232...41,803,656
Ensembl chr X:41,773,232...41,803,653
G
RCL1
RNA terminal phosphate cyclase like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:217,142,965...217,204,960
Ensembl chr 1:217,142,966...217,204,965
G
RFC4
replication factor C subunit 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:124,589,292...124,604,421
Ensembl chr13:124,589,295...124,604,426
G
RIN3
Ras and Rab interactor 3
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 7:114,035,137...114,166,548
Ensembl chr 7:114,035,353...114,166,539
G
RNASEH2A
ribonuclease H2 subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34254728
NCBI chr 2:66,192,785...66,208,417
Ensembl chr 2:66,193,197...66,207,697
G
RNF43
ring finger protein 43
severity
ISO
human cells in a mouse model
RGD
PMID:31286874
RGD:151361222
NCBI chr12:34,631,574...34,695,021
Ensembl chr12:34,635,228...34,694,378
G
ROS1
ROS proto-oncogene 1, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 1:44,409,877...44,535,784
Ensembl chr 1:44,410,351...44,534,874
G
RPL10A
ribosomal protein L10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:31,327,763...31,330,624
Ensembl chr 7:31,327,440...31,333,638
G
RPL13A
ribosomal protein L13a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:54,551,772...54,568,752
Ensembl chr 6:54,551,533...54,561,489
G
RPL27A
ribosomal protein L27a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:708,531...712,410
Ensembl chr 9:707,693...711,219
G
RPSA
ribosomal protein SA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:24,072,551...24,081,536
Ensembl chr13:24,072,527...24,081,541
G
RRM1
ribonucleotide reductase catalytic subunit M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:6,026,151...6,065,211
Ensembl chr 9:6,025,073...6,065,143
G
RRM2
ribonucleotide reductase regulatory subunit M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:126,357,198...126,367,145
Ensembl chr 3:126,347,819...126,365,644
G
RRS1
ribosome biogenesis regulator 1 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:68,285,803...68,288,213
Ensembl chr 4:68,285,803...68,288,195
G
RUNX1
RUNX family transcription factor 1
ISO
RGD
PMID:28926105
RGD:126779571
NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
G
SATB1
SATB homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:5,315,985...5,410,686
Ensembl chr13:5,314,148...5,417,610
G
SDC1
syndecan 1
ISO
mRNA:increased expression:lung (human)
RGD
PMID:23374247
RGD:151708716
NCBI chr 3:117,987,585...118,011,886
Ensembl chr 3:117,987,557...118,011,884
G
SERPINA3-2
alpha-1-antichymotrypsin 2
ISO
protein:increased expression:cytoplasm
RGD
PMID:8620411
RGD:5147446
NCBI chr 7:115,978,453...115,987,392
Ensembl chr 7:115,976,397...115,987,453
G
SETD2
SET domain containing 2, histone lysine methyltransferase
ameliorates exacerbates severity
ISO
human cells and genes in mouse model DNA:mutations:multiple (human)
RGD
PMID:27687306 PMID:28202515 PMID:33223508 PMID:33707235
RGD:126848875 RGD:150429633 RGD:150429648 RGD:150429649
NCBI chr13:29,884,708...29,996,285
Ensembl chr13:29,884,719...29,996,359
G
SFN
stratifin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 6:84,188,521...84,189,824
Ensembl chr 6:84,188,445...84,189,827
G
SFTPC
surfactant protein C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25851810
NCBI chr14:6,440,309...6,443,104
Ensembl chr14:6,440,309...6,443,095
G
SFXN1
sideroflexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:82,025,799...82,057,629
Ensembl chr 2:82,025,820...82,057,564
G
SHMT1
serine hydroxymethyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:60,414,421...60,435,451
Ensembl chr12:60,416,463...60,435,450
G
SLC15A2
solute carrier family 15 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:138,595,942...138,634,473
Ensembl chr13:138,595,973...138,632,675
G
SLC19A1
solute carrier family 19 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:207,986,094...208,007,855
Ensembl chr13:207,986,098...208,007,675
G
SLC1A5
solute carrier family 1 member 5
disease_progression
ISO
RGD
PMID:26279756
RGD:151361150
NCBI chr 6:52,647,432...52,661,464
Ensembl chr 6:52,647,438...52,661,459
G
SLC22A18
solute carrier family 22 member 18
disease_progression
ISO
mRNA:increased expression:lung (human) ClinVar Annotator: match by term: Lung adenocarcinoma
RGD ClinVar
PMID:27993330 PMID:32726996
RGD:150557423
NCBI chr 2:2,032,370...2,055,756
Ensembl chr 2:2,028,396...2,055,750
G
SLC3A2
solute carrier family 3 member 2
disease_progression
ISO
RGD
PMID:19171406
RGD:151361151
NCBI chr 2:8,892,071...8,919,070
Ensembl chr 2:8,892,089...8,919,072
G
SLC4A4
solute carrier family 4 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:67,768,955...68,177,213
Ensembl chr 8:67,706,874...68,177,212
G
SLC4A7
solute carrier family 4 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:13,933,552...14,043,108
Ensembl chr13:13,933,711...14,043,058
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
RGD
PMID:19171406 PMID:26279756
RGD:151361150 RGD:151361151
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
SMAD4
SMAD family member 4
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:6604412 PMID:8898652 PMID:9214508 PMID:9285566 PMID:9582123 PMID:9679244 PMID:9811934 PMID:10479724 PMID:10764709 PMID:10775259 PMID:10797267 PMID:11274206 PMID:11583957 PMID:12116240 PMID:12821112 PMID:14715079 PMID:15014009 PMID:15031030 PMID:15235019 PMID:16613914 PMID:17873119 PMID:17994767 PMID:18823382 PMID:20101697 PMID:20301642 PMID:22316667 PMID:22331366 PMID:25741868 PMID:26572829 PMID:26619011 PMID:26900293 PMID:27595937 PMID:28492532 PMID:31837202 PMID:32300199 PMID:32573726 PMID:32944796 More...
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
G
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:30,409,979...30,576,270
Ensembl chr13:30,409,983...30,576,327
G
SNRPB
small nuclear ribonucleoprotein polypeptides B and B1
severity
ISO
mRNA:increased expression:lung (human)
RGD
PMID:22876301
RGD:10768834
NCBI chr17:33,072,104...33,094,847
Ensembl chr17:33,080,407...33,094,602
G
SNRPE
small nuclear ribonucleoprotein polypeptide E
severity
ISO
mRNA:increased expression:lung (human)
RGD
PMID:22876301
RGD:10768834
NCBI chr 9:64,560,544...64,567,007
Ensembl chr 9:64,560,523...64,567,007
G
SNRPG
small nuclear ribonucleoprotein polypeptide G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:72,198,722...72,208,053
Ensembl chr 3:72,198,756...72,208,865
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
SOS1
SOS Ras/Rac guanine nucleotide exchange factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 3:101,209,568...101,366,057
Ensembl chr 3:101,209,641...101,362,723
G
SOX2
SRY-box transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25184679
NCBI chr13:119,668,476...119,669,435
Ensembl chr13:119,668,476...119,669,435
G
SOX30
SRY-box transcription factor 30
disease_progression
ISO
RGD
PMID:26330328
RGD:11535423
NCBI chr16:65,642,107...65,677,693
Ensembl chr16:65,642,223...65,678,047
G
SOX4
SRY-box transcription factor 4
ISO
protein:increased expression:lung
RGD
PMID:29882245
RGD:153297792
NCBI chr 7:16,886,834...16,895,488
Ensembl chr 7:16,891,319...16,892,752
G
SPOP
speckle type BTB/POZ protein
ameliorates
ISO
mRNA, protein:increased expression:lung (human) human gene and cell line in mouse model
RGD
PMID:30607139 PMID:31105033
RGD:153298920 RGD:153298927
NCBI chr12:25,792,621...25,860,630
Ensembl chr12:25,792,630...25,860,595
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
severity
ISO
RGD
PMID:12826049
RGD:150521546
NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860
G
SRM
spermidine synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:71,246,895...71,253,534
Ensembl chr 6:71,246,876...71,253,508
G
SRR
serine racemase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:48,386,915...48,407,917
Ensembl chr12:48,386,881...48,408,039
G
SRSF1
serine and arginine rich splicing factor 1
severity
ISO
RGD
PMID:23071587
RGD:150429662
NCBI chr12:34,278,363...34,282,164
Ensembl chr12:34,272,956...34,282,162
G
SRSF2
serine and arginine rich splicing factor 2
severity
ISO
RGD
PMID:23071587
RGD:150429662
NCBI chr12:4,800,578...4,803,767
Ensembl chr12:4,800,624...4,801,675
G
STK11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 2:77,229,888...77,249,322
Ensembl chr 2:77,230,372...77,249,327
G
STK39
serine/threonine kinase 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:74,441,019...74,757,851
Ensembl chr15:74,447,787...74,758,122
G
STRBP
spermatid perinuclear RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:264,030,135...264,195,908
Ensembl chr 1:264,045,669...264,195,883
G
SUCLG2
succinate-CoA ligase GDP-forming subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:48,650,851...49,090,521
Ensembl chr13:48,823,733...49,090,468
G
TERT
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP:: rs2736100(human) DNA:SNP::rs33963617(human) DNA:SNPs:: rs2853669,rs2736108(human) DNA:SNP: :rs2736098(human)
RGD
PMID:19955392 PMID:23738012 PMID:23908149 PMID:24761905 PMID:31935503
RGD:150530485 RGD:150530498 RGD:150530502 RGD:150530628 RGD:150530635
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TF
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
G
TGFB2
transforming growth factor beta 2
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr10:8,306,136...8,435,307
Ensembl chr10:8,305,539...8,390,341
G
TIMM10
translocase of inner mitochondrial membrane 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:13,393,225...13,396,241
Ensembl chr 2:13,393,282...13,396,439
G
TIMM8A
translocase of inner mitochondrial membrane 8A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:82,978,128...82,981,038
Ensembl chr X:82,974,270...82,980,769
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:23374247
RGD:151708716
NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581
G
TK1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917
G
TLR4
toll like receptor 4
ISO
ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:27993330
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24345465
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
G
TOMM40
translocase of outer mitochondrial membrane 40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:51,359,948...51,369,932
Ensembl chr 6:51,359,595...51,369,908
G
TOP2A
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:22,001,300...22,028,452
Ensembl chr12:22,001,282...22,028,450
G
TP53
tumor protein p53
ISO
ClinVar Annotator: match by term: Adenocarcinoma of lung | ClinVar Annotator: match by term: Lung adenocarcinoma
ClinVar
PMID:1565144 PMID:1631137 PMID:2046748 PMID:7732013 PMID:8423216 PMID:9067756 PMID:9242456 PMID:9399838 PMID:10864200 PMID:11370630 PMID:11782540 PMID:12672316 PMID:12700230 PMID:12826609 PMID:14743206 PMID:15390294 PMID:15607980 PMID:15607981 PMID:15951970 PMID:16401470 PMID:16818505 PMID:17540308 PMID:17606709 PMID:17636407 PMID:18511570 PMID:19405127 PMID:19454241 PMID:19930417 PMID:20128691 PMID:20407015 PMID:20516128 PMID:20522432 PMID:20693561 PMID:21331359 PMID:21343334 PMID:21484931 PMID:21519010 PMID:21552135 PMID:21761402 PMID:22186996 PMID:22551548 PMID:22653678 PMID:22811390 PMID:22915647 PMID:23161690 PMID:23246812 PMID:23255406 PMID:23334668 PMID:24382691 PMID:24677579 PMID:25584008 PMID:25741868 PMID:25787918 PMID:25952993 PMID:26014290 PMID:26225655 PMID:26230955 PMID:26332594 PMID:26467025 PMID:26585234 PMID:26681312 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27501770 PMID:27680515 PMID:27726232 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28453743 PMID:28492532 PMID:28573494 PMID:28873162 PMID:29324801 PMID:29489754 PMID:29979965 PMID:30107858 PMID:30224644 PMID:30327374 PMID:30607672 PMID:30630526 PMID:30816478 PMID:31081129 PMID:31119730 PMID:31775759 PMID:31882575 PMID:32295079 PMID:32906206 PMID:33300245 PMID:33372952 PMID:33471991 PMID:33758026 PMID:34049842 PMID:34240179 PMID:35974385 PMID:36329109 PMID:36988593 More...
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TP63
tumor protein p63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24880342
NCBI chr13:127,115,990...127,347,082
Ensembl chr13:127,116,105...127,347,068
G
TPI1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:63,839,473...63,842,853
Ensembl chr 5:63,838,506...63,843,134
G
TRAF4
TNF receptor associated factor 4
ISO
mRNA:increased expression:lung (human)
RGD
PMID:29254206
RGD:151665107
NCBI chr12:44,975,639...44,981,650
Ensembl chr12:44,975,632...44,987,104
G
TTF1
transcription termination factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25851810
NCBI chr 1:272,180,488...272,212,504
Ensembl chr 1:272,180,498...272,212,478
G
TTR
transthyretin
ISO
mRNA,protein:increased expression:lung (human)
RGD
PMID:26943652
RGD:151665207
NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
G
TYMS
thymidylate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:105,642,730...105,660,279
Ensembl chr 6:105,642,381...105,660,578
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:32867711
RGD:151665200
NCBI chr 4:34,645,794...34,794,510
Ensembl chr 4:34,645,809...34,793,940
G
UCK2
uridine-cytidine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:84,838,793...84,919,231
Ensembl chr 4:84,838,802...84,919,236
G
VAV1
vav guanine nucleotide exchange factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27158780
NCBI chr 2:72,327,433...72,391,649
Ensembl chr 2:72,326,716...72,391,648
G
WRAP53
WD repeat containing antisense to TP53
severity
ISO
RGD
PMID:28347242
RGD:21081522
NCBI chr12:52,954,674...52,968,371
Ensembl chr12:52,954,669...52,968,364
G
XPC
XPC complex subunit, DNA damage recognition and repair factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21327329 PMID:27777383
NCBI chr13:70,348,841...70,397,194
Ensembl chr13:70,348,864...70,397,772
G
XPO1
exportin 1
exacerbates
ISO
mRNA:increased expression:lung (human) circRNA:increased expression:lung (human)
RGD
PMID:23639940 PMID:33268793
RGD:151665799 RGD:151665801
NCBI chr 3:80,255,016...80,300,260
Ensembl chr 3:80,255,146...80,300,327
G
XRCC1
X-ray repair cross complementing 1
severity susceptibility
ISO
DNA:missense mutation:exon 10: p.R399Q (rs25487) (human) DNA:missense mutation:cds: p.R399Q (human)
RGD
PMID:11104903 PMID:20003463
RGD:151347406 RGD:151347422
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
G
XRCC5
X-ray repair cross complementing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:118,354,943...118,451,974
Ensembl chr15:118,354,796...118,451,960
G
XRCC6
X-ray repair cross complementing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:6,903,496...6,929,162
Ensembl chr 5:6,903,495...6,929,052
G
ZFHX3
zinc finger homeobox 3
ameliorates
ISO
DNA:mutations:multiple (human)
RGD
PMID:32653938
RGD:151361163
NCBI chr 6:15,693,987...15,941,301
Ensembl chr 6:15,698,199...15,863,270
G
ARHGAP44
Rho GTPase activating protein 44
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:28527113
RGD:401901290
NCBI chr12:57,049,900...57,206,706
Ensembl chr12:57,049,895...57,206,889
G
CHRNA5
cholinergic receptor nicotinic alpha 5 subunit
ISO
mRNA:increased expression:lung
RGD
PMID:20124469
RGD:150527851
NCBI chr 7:47,382,860...47,425,871
Ensembl chr 7:47,383,792...47,425,841
G
DLL4
delta like canonical Notch ligand 4
treatment
ISO
RGD
PMID:33628824
RGD:155663482
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
NOTCH1
notch receptor 1
treatment
ISO
RGD
PMID:33628824
RGD:155663482
G
PTPN13
protein tyrosine phosphatase non-receptor type 13
ISO
mRNA,protein:decreased expression:lung
RGD
PMID:22245727
RGD:152176663
NCBI chr 8:132,035,170...132,200,425
Ensembl chr 8:132,035,151...132,249,411
G
TTR
transthyretin
ISO
protein:increased expression:lung (human)
RGD
PMID:26943652
RGD:151665207
NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
G
DAXX
death domain associated protein
exacerbates
ISO
protein:decreased expression:lung (human)
RGD
PMID:28004751
RGD:152025202
NCBI chr 7:29,676,854...29,681,145
Ensembl chr 7:29,676,856...29,681,110
G
TNIK
TRAF2 and NCK interacting kinase
ISO
mRNA,protein:increased expression:lung (human)
RGD
PMID:25250715
RGD:151347838
NCBI chr13:109,642,848...110,052,345
Ensembl chr13:109,643,895...110,052,236
G
ALK
ALK receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532
NCBI chr 3:109,411,146...110,105,755
G
ARHGAP44
Rho GTPase activating protein 44
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:28527113
RGD:401901290
NCBI chr12:57,049,900...57,206,706
Ensembl chr12:57,049,895...57,206,889
G
ARID1A
AT-rich interaction domain 1A
exacerbates
ISO
protein:decreased expression:lung (human)
RGD
PMID:32823232
RGD:126848760
NCBI chr 6:84,049,729...84,124,302
Ensembl chr 6:84,049,087...84,123,349
G
ARPC5
actin related protein 2/3 complex subunit 5
ISO
mRNA:increased expression:lung (human)
RGD
PMID:22089643
RGD:11049488
NCBI chr 9:124,839,062...124,847,906
Ensembl chr 9:124,837,765...124,848,105
G
ATM
ATM serine/threonine kinase
susceptibility
ISO
DNA:SNP:intron:(rs228589) (human)
RGD
PMID:28642860
RGD:150383339
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,657...36,759,552
G
ATRX
ATRX chromatin remodeler
severity
ISO
RGD
PMID:31374064
RGD:127285382
NCBI chr X:61,584,028...61,872,341
Ensembl chr X:61,584,848...61,872,287
G
BIRC5
baculoviral IAP repeat containing 5
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BIRC6
baculoviral IAP repeat containing 6
disease_progression
ISO
mRNA:increased expression:lung (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 3:107,012,967...107,269,370
Ensembl chr 3:107,012,986...107,269,477
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:12068308 PMID:12460918 PMID:12460919 PMID:12960123 PMID:14612909 PMID:15035987 PMID:16439621 PMID:16474404 PMID:17603483 PMID:18042262 PMID:18186519 PMID:18794803 PMID:19010912 PMID:19206169 PMID:19238210 PMID:19537845 PMID:20350999 PMID:21062266 PMID:21129611 PMID:21483012 PMID:21784453 PMID:22310681 PMID:22649091 PMID:22773810 PMID:23273605 PMID:23833300 PMID:24033266 PMID:24303953 PMID:24446311 PMID:24920063 PMID:25157968 PMID:25463315 PMID:25741868 PMID:26619011 PMID:27236105 PMID:27276561 PMID:28492532 PMID:29907801 PMID:31336229 More...
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
BSG
basigin
ISO
mRNA:increased expression:lung
RGD
PMID:9154157
RGD:2289059
NCBI chr 2:77,735,586...77,743,451
G
CBLB
Cbl proto-oncogene B
disease_progression
ISO
RGD
PMID:29384143
RGD:150540336
NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056
G
CCND1
cyclin D1
disease_progression
ISO
protein:increased expression:lung
RGD
PMID:27498289
RGD:13434929
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCND2
cyclin D2
ISO
DNA:hypermethylation:promoter
RGD
PMID:30308939
RGD:151665105
NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571
G
CDK4
cyclin dependent kinase 4
ISO
protein:increased expression:lung
RGD
PMID:9751261
RGD:13464277
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:8552400 PMID:8573142 PMID:9053859 PMID:9660926 PMID:10498896 PMID:15235029 PMID:15860862 PMID:16354195 PMID:16905682 PMID:18024887 PMID:21325014 PMID:21462282 PMID:22368299 PMID:22841127 PMID:24659262 PMID:25356972 PMID:25741868 PMID:25780468 PMID:26681309 PMID:26775776 PMID:28492532 PMID:28592523 PMID:35001868 PMID:36139606 More...
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CHD4
chromodomain helicase DNA binding protein 4
ISO
mRNA:increased expression:lung (human)
RGD
PMID:28486105
RGD:153323299
NCBI chr 5:64,071,627...64,105,212
Ensembl chr 5:64,065,992...64,105,173
G
CHRNA5
cholinergic receptor nicotinic alpha 5 subunit
susceptibility
ISO
mRNA:increased expression:lung DNA:SNP: :rs503464(human)
RGD
PMID:20124469 PMID:23314339
RGD:150527849 RGD:150527851
NCBI chr 7:47,382,860...47,425,871
Ensembl chr 7:47,383,792...47,425,841
G
CHRNB4
cholinergic receptor nicotinic beta 4 subunit
susceptibility
ISO
mRNA:increased expression:lung DNA:hypomethylation:promoter: DNA:SNP:: (rs7178270) (human)
RGD
PMID:20124469 PMID:22945651 PMID:23397474
RGD:150527851 RGD:151361148 RGD:151361154
NCBI chr 7:47,338,819...47,359,064
G
CLPTM1L
CLPTM1 like
susceptibility no_association
ISO
DNA:SNP:: rs31490(human) DNA:SNP: :rs401681(human) DNA:SNP::rs401681(human) mRNA:increased expression:lung
RGD
PMID:23908149 PMID:24366883 PMID:24386361 PMID:24861918
RGD:150530483 RGD:150530498 RGD:150530499 RGD:150537098
NCBI chr16:79,237,000...79,248,503
Ensembl chr16:79,237,061...79,248,500
G
CREBBP
CREB binding protein
ISO
ClinVar Annotator: match by term: Squamous cell carcinoma of lung
ClinVar
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
NCBI chr 3:38,388,366...38,530,243
Ensembl chr 3:38,388,547...38,530,224
G
CSF1R
colony stimulating factor 1 receptor
ISO
protein:increased expression:lung (human)
RGD
PMID:23702648
RGD:150524280
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CTNNB1
catenin beta 1
disease_progression
ISO
protein:increased expression:lung
RGD
PMID:27498289
RGD:13434929
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
CYCS
cytochrome c, somatic
treatment
ISO
RGD
PMID:25578497
RGD:13792769
NCBI chr18:47,169,921...47,172,212
Ensembl chr18:47,169,866...47,173,866
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
susceptibility
ISO
Carcinoma, Squamous Cell;DNA:snp:cds:p.A119S (human)
RGD
PMID:10739169
RGD:7829734
NCBI chr 3:102,195,743...102,205,687
Ensembl chr 3:102,195,741...102,205,683
G
DDR2
discoidin domain receptor tyrosine kinase 2
severity
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
RGD ClinVar
PMID:22328973 PMID:24885564 PMID:25741868 PMID:26206333 PMID:28492532
RGD:150429702
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296
G
E2F1
E2F transcription factor 1
treatment
ISO
RGD
PMID:28927142
RGD:13464332
NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883
G
E2F3
E2F transcription factor 3
ISO
RGD
PMID:16938365
RGD:13464341
NCBI chr 7:15,793,519...15,870,213
Ensembl chr 7:15,794,178...15,870,204
G
EEF2
eukaryotic translation elongation factor 2
disease_progression
ISO
protein:increased expression:lung (human)
RGD
PMID:27542262
RGD:153298910
NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680
G
EGFR
epidermal growth factor receptor
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:20942962 PMID:24033266 PMID:25382819 PMID:25741868 PMID:27294619 PMID:28492532 PMID:30098700 PMID:30610926 PMID:31721094 PMID:32171629 PMID:32978515 PMID:32978518 PMID:1111234672 More...
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EMX2
empty spiracles homeobox 2
exacerbates
ISO
protein:decreased expression:lung (human)
RGD
PMID:26132438
RGD:11079903
NCBI chr14:127,649,675...127,656,972
Ensembl chr14:127,650,688...127,655,706
G
ERCC6
ERCC excision repair 6, chromatin remodeling factor
ISO
mRNA, protein:increased expression:lung (human)
RGD
PMID:31615563
RGD:155260344
NCBI chr14:89,998,125...90,075,911
Ensembl chr14:90,002,024...90,075,898
G
ERCC6L
ERCC excision repair 6 like, spindle assembly checkpoint helicase
ISO
mRNA:increased expression:lung (human)
RGD
PMID:35150321
RGD:155260359
NCBI chr X:58,087,216...58,117,942
Ensembl chr X:58,087,169...58,117,947
G
FAP
fibroblast activation protein alpha
disease_progression
ISO
RGD
PMID:26252379
RGD:152600901
NCBI chr15:68,831,281...68,902,416
Ensembl chr15:68,830,730...68,902,379
G
FBXW7
F-box and WD repeat domain containing 7
ISO
ClinVar Annotator: match by term: Squamous cell carcinoma of lung | ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:25741868 PMID:26619011
NCBI chr 8:76,482,027...76,699,354
Ensembl chr 8:76,482,844...76,699,348
G
FGF9
fibroblast growth factor 9
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:28440022
RGD:152180844
NCBI chr11:1,554,648...1,581,938
Ensembl chr11:1,554,763...1,582,408
G
FGFR2
fibroblast growth factor receptor 2
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
NCBI chr14:131,183,095...131,285,001
Ensembl chr14:131,181,713...131,289,425
G
FGFR3
fibroblast growth factor receptor 3
ISO
ClinVar Annotator: match by term: Squamous cell carcinoma of lung | ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:8589699 PMID:10471491 PMID:11038465 PMID:11879084 PMID:15772091 PMID:17384684 PMID:19749790 PMID:20301540 PMID:25606676 PMID:25614871 PMID:25741868 PMID:28492532 More...
NCBI chr 8:879,151...894,968
Ensembl chr 8:879,159...894,964
G
FGFR4
fibroblast growth factor receptor 4
disease_progression
ISO
human cells in mouse model
RGD
PMID:29402970
RGD:150429984
NCBI chr 2:80,841,536...80,853,791
Ensembl chr 2:80,841,536...80,853,796
G
FRZB
frizzled related protein
ISO
protein:decreased expression:lung (human)
RGD
PMID:27623992
RGD:32716395
NCBI chr15:88,332,856...88,377,275
Ensembl chr15:88,332,860...88,377,247
G
FUBP1
far upstream element binding protein 1
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:32481602
RGD:151361197
NCBI chr 6:135,281,474...135,319,055
Ensembl chr 6:135,281,521...135,318,714
G
GPX1
glutathione peroxidase 1
susceptibility
ISO
DNA:missense mutation:CDS:p.P198L (rs1050450) (human) DNA:missense mutation:CDS:p.P200L (rs1050450) (human)
RGD
PMID:16797832 PMID:18298806
RGD:152995481 RGD:152995507
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
HRAS
HRas proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:16372351 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
protein:increased expression:blood plasma (human)
RGD
PMID:24046070
RGD:149735540
NCBI chr15:111,341,153...111,362,330
Ensembl chr15:111,341,153...111,362,296
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
severity susceptibility
ISO
protein:increased expression:blood serum (human) protein:increased expression:lung (human) DNA:SNP:CD: (rs11540478) C>T (human)
RGD
PMID:27649069 PMID:29465809 PMID:30128035
RGD:149735564 RGD:149735566 RGD:149735567
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:25741868
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
KMT2D
lysine methyltransferase 2D
disease_progression
ISO
RGD
PMID:24323028 PMID:28177435 PMID:30885352
RGD:150523770 RGD:150523776 RGD:150523777
NCBI chr 5:15,049,827...15,091,622
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:6695174 PMID:15696205 PMID:17704260 PMID:26242988 PMID:28492532
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LAMC2
laminin subunit gamma 2
disease_progression
ISO
RGD
PMID:23124251
RGD:13793371
NCBI chr 9:124,427,545...124,499,672
Ensembl chr 9:124,435,807...124,495,351
G
LRRC56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:16372351 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr 2:303,836...323,701
Ensembl chr 2:304,430...323,699
G
MAP2K1
mitogen-activated protein kinase kinase 1
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:25741868
NCBI chr 1:164,381,892...164,469,313
Ensembl chr 1:164,381,845...164,471,226
G
MAP2K7
mitogen-activated protein kinase kinase 7
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:31089135
RGD:155253742
NCBI chr 2:71,299,010...71,308,432
Ensembl chr 2:71,298,325...71,308,124
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MIR193A
microRNA mir-193a
exacerbates
ISO
DNA:Hypermethylation
RGD
PMID:22282464
RGD:153344598
NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048
G
MIR20A
microRNA mir-20a
ISO
RGD
PMID:26560875
RGD:11572141
NCBI chr11:60,735,109...60,735,179
Ensembl chr11:60,735,099...60,735,196
G
MIR31
microRNA mir-31
severity
ISO
RNA:increased expression:blood serum (human) RNA:increased expression:lung (human)
RGD
PMID:21658006 PMID:21890451
RGD:152998938 RGD:152998950
NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809
G
MIR497
microRNA mir-497
ISO
RGD
PMID:31115562
RGD:126925181
NCBI chr12:52,422,329...52,422,408
Ensembl chr12:52,422,330...52,422,411
G
MIR9-3
microRNA mir-9-3
exacerbates
ISO
DNA:Hypermethylation
RGD
PMID:22282464
RGD:153344598
NCBI chr 7:54,948,452...54,948,532
Ensembl chr 7:54,948,447...54,948,536
G
PDGFRA
platelet derived growth factor receptor alpha
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr 8:40,966,568...41,021,440
Ensembl chr 8:40,967,493...41,021,441
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:25741868
NCBI chr13:117,193,935...117,282,151
Ensembl chr13:117,180,544...117,274,587
G
POLE
DNA polymerase epsilon, catalytic subunit
ameliorates
ISO
DNA:mutations:multiple (human)
RGD
PMID:29650000
RGD:151347653
NCBI chr14:22,798,146...22,852,818
Ensembl chr14:22,798,192...22,853,547
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
ISO
mRNA:increased expression:lung (human)
RGD
PMID:32537022
RGD:151665184
NCBI chr 4:66,712,412...66,996,258
Ensembl chr 4:66,715,237...66,996,044
G
PTCH1
patched 1
disease_progression
ISO
DNA:CNVs
RGD
PMID:21889114
RGD:150524337
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
G
PTEN
phosphatase and tensin homolog
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
NCBI chr14:99,929,590...100,021,619
G
PTK2
protein tyrosine kinase 2
severity
ISO
RGD
PMID:23906871
RGD:152176664
NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
ClinVar Annotator: match by term: Squamous cell carcinoma of lung
ClinVar
PMID:11704759 PMID:12634870 PMID:12717436 PMID:14644997 PMID:14974085 PMID:14982869 PMID:15385933 PMID:15842656 PMID:15928039 PMID:16830086 PMID:18470943 PMID:18678287 PMID:19047918 PMID:19509418 PMID:21930766 PMID:23825065 PMID:24033266 PMID:25741868 PMID:26619011 PMID:27783593 PMID:28492532 More...
NCBI chr14:39,202,165...39,292,041
Ensembl chr14:39,202,169...39,292,003
G
PTPN13
protein tyrosine phosphatase non-receptor type 13
susceptibility severity
ISO
mRNA,protein:decreased expression:lung DNA:missense mutations:cds:p.I1522M, p.Y2081D (human)
RGD
PMID:19672627 PMID:22245727 PMID:23906871
RGD:152176663 RGD:152176664 RGD:152176665
NCBI chr 8:132,035,170...132,200,425
Ensembl chr 8:132,035,151...132,249,411
G
PTPRJ
protein tyrosine phosphatase receptor type J
susceptibility
ISO
DNA:missense mutations:cds:p.R326Q, p.Q276P (human)
RGD
PMID:19672627
RGD:152176665
NCBI chr 2:14,548,489...14,724,823
Ensembl chr 2:14,548,428...14,724,474
G
RAD52
RAD52 homolog, DNA repair protein
susceptibility ameliorates
ISO
DNA:SNP: (rs6489769) (human)
RGD
PMID:22585858 PMID:28415565
RGD:151660334 RGD:151660345
NCBI chr 5:68,140,846...68,223,587
Ensembl chr 5:68,143,646...68,169,670
G
SFTPB
surfactant protein B
susceptibility
ISO
DNA:polymorphism:intron (human) DNA:variants:intron:
RGD
PMID:12107845 PMID:16570259
RGD:151667424 RGD:4143389
NCBI chr 3:59,101,940...59,113,442
Ensembl chr 3:59,101,981...59,112,396
G
SLC7A5
solute carrier family 7 member 5
ISO
RGD
PMID:19068093
RGD:151361158
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
SOX30
SRY-box transcription factor 30
disease_progression
ISO
RGD
PMID:26330328
RGD:11535423
NCBI chr16:65,642,107...65,677,693
Ensembl chr16:65,642,223...65,678,047
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
severity
ISO
RGD
PMID:12826049
RGD:150521546
NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860
G
SRSF1
serine and arginine rich splicing factor 1
ISO
protein:increased expression:lung epithelium
RGD
PMID:23071587
RGD:150429662
NCBI chr12:34,278,363...34,282,164
Ensembl chr12:34,272,956...34,282,162
G
SRSF2
serine and arginine rich splicing factor 2
ISO
protein:increased expression:lung epithelium,nucleus
RGD
PMID:23071587
RGD:150429662
NCBI chr12:4,800,578...4,803,767
Ensembl chr12:4,800,624...4,801,675
G
STK11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:15800014 PMID:17676035 PMID:25741868 PMID:28492532
NCBI chr 2:77,229,888...77,249,322
Ensembl chr 2:77,230,372...77,249,327
G
TERT
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP:: rs2853669(human) DNA:SNP::rs33963617(human)
RGD
PMID:23908149 PMID:31935503
RGD:150530498 RGD:150530635
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TP53
tumor protein p53
ISO
ClinVar Annotator: match by term: Squamous cell lung carcinoma
ClinVar
PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1915267 PMID:1918170 PMID:1978757 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:4122735 PMID:6736287 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7732013 PMID:7750099 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8633021 PMID:8688334 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8829653 PMID:8869100 PMID:9020384 PMID:9049183 PMID:9150393 PMID:9157982 PMID:9218725 PMID:9242456 PMID:9290701 PMID:9364015 PMID:9407971 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9667734 PMID:9825943 PMID:9839505 PMID:9979965 PMID:10064694 PMID:10089074 PMID:10229196 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10713666 PMID:10753186 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:10949938 PMID:11051239 PMID:11051241 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11590071 PMID:11593407 PMID:11668501 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12124823 PMID:12509279 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12702523 PMID:12726864 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15077194 PMID:15138567 PMID:15161705 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15977174 PMID:15982667 PMID:15993273 PMID:16206219 PMID:16209708 PMID:16258005 PMID:16288208 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16489069 PMID:16492679 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16778209 PMID:16793544 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17540308 PMID:17541742 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17875924 PMID:17881637 PMID:18208484 PMID:18307025 PMID:18453682 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18978813 PMID:18989156 PMID:19012332 PMID:19101993 PMID:19171880 PMID:19336573 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19462533 PMID:19468865 PMID:19556618 PMID:19681600 PMID:19834951 PMID:19850740 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20127978 PMID:20128691 PMID:20195489 PMID:20234365 PMID:20308654 PMID:20364130 PMID:20407015 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20589832 PMID:20693561 PMID:20805372 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21113594 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21522129 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21626334 PMID:21674059 PMID:21747090 PMID:21760960 PMID:21760996 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22109999 PMID:22110706 PMID:22114072 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22484423 PMID:22553421 PMID:22672556 PMID:22710932 PMID:22713868 PMID:22768918 PMID:22811390 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22999923 PMID:23124483 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23264849 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23340422 PMID:23406775 PMID:23484829 PMID:23538418 PMID:23612969 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24076587 PMID:24122735 PMID:24256616 PMID:24307375 PMID:24381225 PMID:24384472 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24549055 PMID:24573247 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24763289 PMID:24810334 PMID:24835218 PMID:24940547 PMID:25119136 PMID:25123297 PMID:25157968 PMID:25186627 PMID:25293557 PMID:25339994 PMID:25428789 PMID:25433984 PMID:25503501 PMID:25525159 PMID:25584008 PMID:25619955 PMID:25669829 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26022348 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26534844 PMID:26554828 PMID:26556299 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26659639 PMID:26681312 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27179933 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27523101 PMID:27533082 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27873457 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28176830 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28724667 PMID:28776571 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28975465 PMID:29025599 PMID:29070607 PMID:29126202 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29875428 PMID:29946497 PMID:29979965 PMID:30076369 PMID:30099178 PMID:30128536 PMID:30152528 PMID:30216591 PMID:30224644 PMID:30299350 PMID:30306255 PMID:30311369 PMID:30318520 PMID:30327374 PMID:30352134 PMID:30450585 PMID:30546832 PMID:30630526 PMID:30675318 PMID:30720243 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31016814 PMID:31050713 PMID:31081129 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31206626 PMID:31300551 PMID:31494577 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32187361 PMID:32295079 PMID:32318955 PMID:32401780 PMID:32475984 PMID:32658383 PMID:32817165 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33758026 PMID:34026625 PMID:34266904 PMID:34805717 PMID:35938033 PMID:36988593 More...
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TP73
tumor protein p73
treatment
ISO
mRNA:increased expression:lung (human) DNA:SNP:: rs2273953(human)
RGD
PMID:27246533 PMID:30420492
RGD:151347580 RGD:151347584
NCBI chr 6:65,169,770...65,228,997
Ensembl chr 6:65,182,456...65,228,990
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all